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1Introduction
1.1Protein folding and disulfide bond formation
Proteins are made of amino acids whose sequence is dictated by the
DNA sequence in the gene. To be biologically active, a protein must exhibit
higher levels of structural organization.Therefore,itis important to
understand how a protein folds from a random-coiled polypeptide to a well-
defined structure, both from the standpoint of attaining scientific knowledge
as well as designing effective therapeutic targets.How and why a protein
adopts a specific three-dimensional conformation constitutes the protein
folding problem (Anfinsen 1973). The ultimate goal of solving the protein
folding problem is to be able to predict the folded structure of the protein
from only a knowledge of its primary sequence.
The reversibility of protein unfolding and folding was demonstrated
by Anfinsen with bovine pancreatic ribonuclease (RNase) (Anfinsen 1961).
The native RNase was denatured in 8 M urea and 13-mercaptoethanol; the
unfolded and reduced RNase was readily converted to the native protein2
with fullbiological activity.This experiment established that all the
information necessary to define the native three-dimensional structure of a
protein is contained in its primary sequence.However, for a polypeptide of
100 amino acid residues, the possible conformations are on the order of
103° and would take many years to fold if the polypeptide were to sample all
available conformations (Creighton 1992). How does the polypeptide chain
search in a finite time through the extensive conformational space to find
the native state simply based on its amino acid sequence? Since proteins
fold much more quickly invitro, some on the time scale of seconds,
Levinthalconcludedthatproteinsmustfoldbyspecificpathways
characterized by foldingintermediates(Levinthal1968).Thus, the
detection and structural characterization of foldingintermediates are
important to addressing the protein folding problem.
Often the intermediates along the folding pathways correspond to
transient ensembles of micro-states. Consequently, they cannot be isolated
or characterized in detail.However, in disulfide-containing proteins, the
presence of a disulfide bond between two Cys residues requires that they
be within a few angstroms of each other. Due to the linkage between the
stabilities of the disulfide bonds and the protein conformation that favor
them, the conformation of the protein can be effectively trapped by disulfide
bond quenching, i.e. trapping of the folding intermediates with nascent3
cysteinyl groups by alkylation. Whatever conformation helps promote the
formation of a particular disulfide bond willitself be stabilized by the
presence of that disulfide bond (Figure1).Therefore, the trapped
intermediates tend to adopt the conformations that favor the formation of
these disulfide bonds, assuming that the trapping reaction does not alter the
proteinconformation.This method, termed oxidativefolding, was
developed by T.E.Creighton (Creighton 1977; Creighton 1978) and has
found many applications in the elucidation of protein folding pathways
(Ey les, Radford et al. 1994) (Ruoppolo 2000).
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Figure 1. Disulfide bond formation and protein foldingare interconnected.4
The formation of a disulfide bond between two thiols is a two-electron
oxidation reaction that requires an oxidant. While air oxygen may facilitate
the formation of disulfide bonds, many oxidative folding studies utilize low
molecular weight disulfides such as RSSR/RSH.During oxidation, the
disulfide component (RSSR) of the redox buffer provides the oxidizing
equivalents for protein disulfide formation. The thiol component (RSH) of
the redox buffer serves to reduce the non-native disulfide bonds that may
trap the protein in the incorrect disulfide bonded form.Thiol/disulfide
exchange occurs via direct attack of the thiolate anion on one of the sulfurs
involved in the disulfide bond. The rate constant for the reaction increases
as the basicity of the thiolate increases (pKa increases) and as the basicity
of the leaving group decreases. The rate constant also increases as the pH
of the solution increases until the attacking thiol is predominantly in the
thiolate form. The pKa of a typical cysteine sulfhydryl group is about 8.6
and may change depending on the local environment.
In order to isolate and structurally characterize the intermediates that
are involved in oxidative folding, it is necessary to stop both the inter- and
intramolecular thioVdisulfide exchange reactions and properly trap the
intermediates.Criteria for a good trapping method requires that the
trapping agent block quickly, completely and without modifying the protein5
at sites other than the thiols (Rothwarf 1993). One method that has been
used is to lower the solution pH to <2 by adding acid (Weissman 1991)
(Figure 2). Quenching by acidification is rapid and occurs at the diffusion-
controlled rate (109 M-'s-1).However, acidification does not completely
stop the thiol/disulfide exchange. At pH 2, the thiol disulfide interchange
stilloccurs at10-6ofitsrateat pH 8.Intramolecular disulfide
rearrangement occurs at a rate of up to 105 s-1 with a half-life as short as 7
seconds at pH 2.
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Figure 2. Some commonly used trapping methods.
+HI6
Alternatively,thethiolgroups can be trappedirreversibly by
alkylation. Once all free thiol groups are blocked, the trapped species are
stable and may be analyzed in detail.Traditionally, irreversible alkylation
has been accomplished by adding iodoacetamide (IAM or CAM) or
iodoacetic acid (IAA or CAA). However, rearrangement of disulfides during
trappinghasbeenobserved(Rothwarf1991;Weissman1991).
Modification of other functional groups by the high concentration of
iodoacetamidehasalsobeenreported(Torella1994). Cyano-
dimethylamino-pyridinium salt (CDAP) at low pH offers a number of
advantages over IAM and IAA (Wakselman 1976; Koyama 1994; Wu, Yang
et al. 1998). Cyanylation occurs under acidic conditions where the rate of
sulfhydryVdisulfide exchange is lowered thereby limiting disulfide bond
shuffling.Additionally, cyanylation is selective and modification at sites
other than cysteine residues is rare.However, cyanylated proteins and
peptides may undergo p-elimination under basic conditions.
The structural elucidation of successive folding intermediates is
made possible by the disulfide bond quenching method.However, the
oxidative folding of a protein containing only a few disulfide bonds can be
quite complex.For a protein with six cysteine residues that form three
disulfide bonds, there are 15 ways the first disulfide bonds can form, 457
possible two disulfide bonded species, and 15 different pairings of the
cysteine residues to generate molecules with three disulfide bonds in the
native structure. The complexity rapidly increases when more disulfides are
involved.In studies carried out by Baldwin and Weissman, various folding
intermediates involving non-native disulfides have been identified in the
oxidative folding of bovine pancreatic trypsin inhibitor (Kim 1990; Weissman
1992).The pathways constructed using these and other intermediates
were interesting in that they didn't occur via a simple sequential pathway.
Instead, parallel folding pathways were identified.
1.2Recombinant human macrophage colony stimulating factor [3
Macrophage colony stimulating factor (M-CSF) is a glycoprotein that
stimulates the proliferation, differentiation and survival of cells belonging to
the monocyte-macrophage lineage both in vivo and in vitro (Stanley 1994).
For instance, M-CSF can induce M-CSF dependent proliferationof
fibroblasts (Roussel 1989) or hematopoietic cells (Kato 1990). M-CSF can
also stimulate the differentiation towards monocyte and macrophage
lineage of myeloid progenitor cell lines such as FDC-P1 (Rohschneider
1989) or NFS-60 (Pawlak 1999).The key role of M-CSF in monocytic8
development has been demonstrated in mutant mice that lack functional
M-CSF and are deficient in macrophages but can be cured by the injection
of M-CSF (Wiktor-Jedrejczak 1991).
The effects of M-CSF are mediated by its binding to its receptor (M-
CSFR), which is an integral transmembrane glycoprotein and functions as a
ligand-activated protein tyrosine kinase (Bourette 2000) (Figure 3).
Cytosol
M-CSF dimer
Extracellular
space
IG-like
domains
Cytosol
M-CSFR monomer
Figure3.rhm-CSF93 triggers the development ofcellsbelonging to
monocyte-macrophage lineage.9
M-CSF is the only known ligand for M-CSFR.Ligand binding to the
extracellular region induces dimerization of M-CSFR. Transphosphorylation
of several cytoplasmic tyrosineresiduesisfollowed by subsequent
interaction of the phosphorylated cytoplasmic domain of M-CSFR with
several 'primary' adaptor proteins, each signaling along specific pathways
(Csar 2001). The best characterized signal pathway is the one initiated by
the Grb2-SOS activationofRas, leading to MAP kinase activation
(Treisman 1996). Another major pathway is initiated with binding of Src to
the activated phosphorylated M-CSFR, relieving constraints on the Src
kinase activity (Moarefi 1997).
The original interest in M-CSF stemmed from the hope that M-CSF
may find clinical applicationin diseases characterized by suboptimal
production of specific cell types such as in the treatment of infectious
diseases, various forms of cancer and the management of bone marrow
transplants. However, M-CSF was shown to exhibit much less proliferation
on human bone marrow cells than on comparable populations of murine
bone marrow cells (Cerretti 1988). Contrary to its previously reported role
in bone marrow development, M-CSF does not seem to have any mitogenic
effect on bone marrow cells of human origin (Tushinski 1982).10
Human M-CSF is encoded by a single gene that maps to
chromosome 5q33.1; the primary messenger RNA (mRNA) transcript of this
gene undergoes alternative splicing to generate multiple mature mRNAs
encoding different forms of membrane-bound M-CSF precursors. The three
M-CSF polypeptides differ in length: a contains 256 aa (Kawasaki 1985), 13
consists of 554 aa (Wong 1987), and y is made up of 438aa (Cerretti
1988). All three proteins share a common domain structure consisting ofan
amino-terminal signal peptide followed by a segment of hydrophobic amino
acids that serves as the membrane anchor for the precursor anda short
carboxy-terminal tail.It has been proposed that M-CSF is synthesized asa
membrane bound precursor which is then proteolytically cleaved, releasing
different forms of the soluble growth factor (Rettenmier 1987; Stein 1990).
M-CSFI3 undergoes both asparagine N- and 0-lined glycosylation
and is rapidly cleaved from the transmembrane domain.It is a homodimer
maintained by three inter-subunit and six intra-subunit disulfide bonds
(Figure 4).Helix A
6 c
Cysl 7/159-Cys'157/159
11
Figure 4. Schematic representation of rhm-CS93 based on x-ray crystal
structure of m-CSFa (Pandit, 1992).The unstructured C-terminal
regions (aa157-221) and the disulfide bridges linking Cys157/159-
Cys'157/159 are shown as dotted lines.
The disulfide bridges were assigned using enzymatic digestion and fast
atom bombardment mass spectrometry (FAB-MS) (Glocker, Arbogast et al.
1993). The inter-subunit disulfide bridges hold the dimer together and form
symmetrical bonds in which Cys 31 and Cys157/159 from one monomer
unit were linked to the corresponding cysteines of the second monomer.
The intra-subunit disulfide bonds were found between Cys4-Cys90, Cys48-
Csy139 and Cys102-Cys146.Mutation experiments have shown that the12
Cys 4, 31, 48, 90, 102 and 139 in each chain were essential for biological
activity (Kawasaki 1990). A crystal structure of M-CSFa suggested that
these cysteine residues were important for structure formation or stability
rather than being directly involved in receptor recognition (Pandit 1992).
Two intermolecular disulfide bonds in the C-terminal region were found
between Cys157/159 and Cys'157/159.It is unclear whether Cys157 forms
a disulfide bond with Cys'157 or Cys'159.Nonetheless, it is evident that
these cysteine residues form symmetrical disulfide bonds that are in close
proximity in three-dimensional space.
1.3Hydrogen deuterium exchange (H/D)
Hydrogen deuterium exchange is a powerful technique that has been
used to study protein structure (Zhang 2001), dynamics (Gregory 1986;
Resing 1998), folding (Miranker, Robinson et al. 1993) and protein-ligand
interactions (Anderegg 1995; Kragelund 1995; Wang 1997; Mandell 2001).
Hydrogen deuterium exchange involves the replacement of labile protein-
bound hydrogen with solvent hydrogen of a different isotopic composition,
often deuterium. Proteins contain three types of exchangeable hydrogens:13
those located on the amino acid side chains, those at the N- and the C-
termini, and those at the peptide amide linkages (NHs) (Figure 5).
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Figure 5. Amide hydrogens that undergo isotopic exchange.
Among these hydrogens, only those located at the peptide amide linkages
exchange at a rate that can be readily measured (Englander 1984). Every
amino acid residue, except Pro, has one hydrogen at the peptide amide
linkage.Consequently, NHs can form a continuous string of sensors14
extending the entire length of a polypeptide chain, providing important
structural information.
Amide hydrogens can undergo exchange via three mechanisms
(Perrin 1989): (A) base catalysis which requires the abstraction of the
amide hydrogen by hydroxide ion and subsequent deuteration of the amide
nitrogen by proton/deuterium exchange from the solvent; (B) acid catalysis
whichinvolves the deuterationof the amide nitrogen followed by
deprotonation by solvent; and (C) imidic acid mechanism which involves the
deuteration of the carbonyl oxygen and subsequent removal of the amide
proton by solvent yielding the imidic acid and then the amide (Figure 6).(A)
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Figure 6. Details of the chemical exchange reaction of amide hydrogen. (A)
Base catalysis. (B) Acid catalysis. (C) Imidic acid mechanism.
The base catalysis mechanism dominates at pHs greater than 3.At pHs
less than 3, the imidic acid mechanism has been shown to dominate over
theN-protonationacidcatalysis mechanism due tobetter charge
delocalization in the transition state (Perrin 1982).The exchange rate
constant for a freely exposed NH can be expressed as
K...1(OH[OH-] + NW] + ko Equation 116
where koH, kH, and ko are the rate constants for the base-catalyzed, acid
catalyzed exchange and direct exchange with water, respectively. Detailed
studies of amide H/D exchange in the model polypeptide polyalanine
indicate that koH and kH have values of 1.12X1010 M-1min-1 and 41.7 M-
1min-1, respectively, at 20°C and low concentrations of salt (Bai 1993). The
isotopic exchange rate constants for exposed amide hydrogens of
polyalanine, polar side-chain hydrogens, as well as hydrogens at the N- and
C-termini are given as a function of pH (Figure 7).
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Figure 7. Amide H/D exchange rate constant as a function of pH.17
Direct exchange with H2O is usually ignored because lc, has a value of
0.03 KT imin-1. The exchange rate of NH in an unfolded polypeptide is the
slowest at pH 2.5-3 and increases 10-fold for each pH unit to give a linear
correlation (Figure 8).
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Figure 8. Amide hydrogen exchange rate is related to pH and temperature.
Isotopic exchange of NH is also sensitive to temperature.The rate
constants follow the Arrhenius equation:18
Ink = InA Ea/RT Equation 2
where k is the rate coefficient, A is a constant, Ea is the activation energy, R
is the universal gas constant, and T is the temperature (in degrees Kelvin).
Thus, to predict exchange rate constants at different temperatures the
following equation can be used:
kex,T2 = kex,T1eXP(-Ea(1UT2-1 /Ti )/R) Equation 3
where kex,T2 and kex,ri are the exchange rate constants at temperatures T1
and T2 (K), R is the gas constant and the activation energies Ea for the acid,
base, and water catalyzed exchange are 14 kcal/mol, 17 kcal/mol and 19
kcal/mol (Bai 1993), respectively.Thus, with every 10°C increase in
temperature, the isotopic exchange rate can increase by 3-fold.
The dependence of isotopic exchange rate on pH and temperature
provides the basis for quenching isotopic exchange, thereby facilitating
detailed analysis of labeled proteins (Zhang and Smith 1993). At pH 7 and
25°C, the half-lives of the exposed NHs are in the range of 0.05-0.01 s,
whereas at 0°C and pH 2.5, the half-lives of the exposed NHs range from 1
to 2 hr.In addition to the effects of temperature and pH, solvent
composition also affects the isotopic exchange rates of amide hydrogens.19
Because the equilibrium constant Kb, for water decreases in the presence
oforganicsolvents,theratesforisotopicexchangedecrease.
Consequently, the pHmin shifts to higher values with increasing fraction of
organic solvents.
In polypeptides with random structures where few intramolecular
hydrogen bonds exist and the amide sites are exposed to the solvent, NHs
exchange rapidly.In folded proteins, the rates at which NHs undergo
isotopic exchange appear to depend on whether the hydrogens are
participating in intramolecular hydrogen bonding (i.e.in a-helices or 0-
sheets), and on the extent to which the hydrogens are shielded from the
solvent (Englander 1984), as well as on the depth of the amide residues
(Chakravarty 1999; Yan 2002). Isotopic exchange rate constants for NHs in
folded proteins differ by many orders of magnitude. NHs in folded proteins
or peptides exchange slowly because folded polypeptide chains involve a
complex network of intramolecular hydrogen bonds, and because the folded
structures limit the solvent exposure of NHs. The half-lives for isotopic
exchange, which depend on the structure and the environment of the NH,
typically span the range from milliseconds to months at pH 7.
Hydrogen exchange from folded proteins can be described by two
proposed mechanisms (Li 1999): exchanging from the folded state and
exchanging from the unfolded state (Figure 9).(A)
(B)
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Figure 9. Pictorial presentation of the underlying principle of peptide amide
hydrogen exchange.(A) Hydrogen deuterium exchange from the
folded state.(B) Hydrogen deuterium exchange from the unfolded
state.
The total exchange rate, Kex, is the sum of exchange rate from the folded
state, kf, and the exchange rate from the unfolded state, ku:
Kex = kf + ku Equation 4
Amide hydrogens that exchange directly from the folded state are expected
to dominate for NHs located on peptide bonds near the surface or open21
channels within the folded protein. If the protein is folded at the instant of
hydrogen exchange, the rate constant for isotopic exchange is designated
as kf=f3k, where 8 is the probability of D20 being present at the site, k is the
exchange ratein an unstructured polypeptides and its value can be
calculated. Amide hydrogens exchanging from the unfolded state are often
involved in intramolecular hydrogen bonding.They may undergo local
unfolding, which involves a rapid unfolding and refolding of small regions,
as well as global unfolding that involves the entire protein.In this
mechanism, the isotopic exchange can only take place after intramolecular
hydrogen bonds are broken and the NHs become exposed to the
deuterated solvent. When a protein is unfolded at the instant of hydrogen
exchange, the rate constant for isotope exchange, Ice., is related to k1, k-1,
and k2, as indicated in the following equation (Deng and Smith 1998)
K0, = (k1k2)/(k_l+k2) Equation 5
When the folding rate is much greater than the isotope exchange rate
(k-1 >>k2), a region unfolds and refolds many times before isotope exchange
is complete at all peptide linkages in the local region. This kinetic limit (EX2
kinetics) leads to a random distribution of deuterium in the unfolding region
among all molecules comprising the sample. The mass spectra of peptides22
derived from regions in which deuteriums are distributed randomly
among all molecules exhibit one envelope of isotope peaks. Most proteins
undergo EX2-type kinetics under physiological conditions. When the
refolding rate is much smaller than the isotope exchange rate (k_1 «k2), a
local region becomes completely deuterated the first time it unfolds (EX1
kinetics).In this case, the mass spectra exhibit two envelopes of isotope
peaks, one corresponding to the unexchanged species, the folded state,
and the other representing the exchanged species, the unfolded state.
There are two types of hydrogen exchange experiments, namely
continuous labeling and pulsed labeling (Deng, Zhang et al. 1999).In the
continuous labeling experiments, the protein is exposed to D20 for a certain
time period, while individual molecules fluctuate between folded and
unfolded states. Molecules that are or become unfolded during the labeling
time become deuterated, and molecules that have not yet unfolded during
this time remain protonated. Thus, the deuterium level in a protein labeled
continuously represents the sum of all molecules that unfold during the
deuteration time, which may range from msec to days.In pulsed labeling
experiments, the exposure of the protein to D20 is short relative to the scale
of the folding/unfolding event.Since little folding/unfolding occurs during
the labeling step, the deuterium levels resulting from the pulsed labeling
experiments indicate the instantaneous populations of folded and unfolded23
molecules. The experimental condition for the labeling pulse must be
carefully selected to ensure that alllabile protons can exchange with
solvent deuterium and all inaccessible protons remain shielded from D20.
The optimal duration for exposure of the protein to D20 depends primarily
on pH, temperature, the amino acid sequence as well as the kinetics of the
process of interest. Pulsed labeling hydrogen exchange experiments have
been used to study rapid kinetics of various reactions taking place on the
time scale of msec (Pinheiro 1997; Coyle 1999; Tsui, Garcia et al. 1999).
These experiments require the use of an automated mixing apparatus such
as the BioLogic quenched flow system (Appendix 1).
Most hydrogen exchange experiments involve the exchange of
protein-bound protons for solvent deuteriums, known as the deuterium
exchange-in approach or hydrogen/deuterium (H/D) exchange.In these
experiments, labeled deuteriums represent amide sites that are accessible
to the deuterated solvent at the time of exchange. This approach is useful
for proteins that are difficult to prepare in the fully deuterated form.
However, it suffers from back exchange during HPLC analysis. Therefore,
this method is most appropriate for comparing structures or conformations
between different proteins. Some hydrogen exchange experiments employ
fully deuterated proteins and involve the exchange of protein-bound
deuteriums for solvent protons, termed the deuterium exchange-out24
experiments or deuterium/hydrogen (D/H) exchange. Deuterium labels in
these experiments represent the amide sites that remain inaccessible at the
time of exchange.In D/H experiments, there is a smaller deuterium loss
during HPLC analysis. However, some proteins can be difficult to prepare
in the fully deuterated form in which case they can only be studied by the
deuterium exchange-in method.
1.4Electrospray ionization mass spectrometry (ESI-MS)
Proteins that have undergone H/D exchange can be analyzed by
nuclear magnetic resonance (NMR), which is considered the reference
technique for measuring H/D exchange (Woodward 1999). This is because
NMR is a residue-specific technique,revealing proton or deuterium
occupancy at each amide site averaged over all molecules.However,
hydrogen exchange studies monitored using NMR are restricted to large
quantities (protein concentration of 1-2 mM) of highly soluble proteins with
medium molecular weights (< 30,000 Da).
Mass spectrometry (MS) has become an important method for
studying hydrogen exchange in proteins (Zhang and Smith 1993).This
approach joins solution phase hydrogen exchange and mass spectrometric25
measurement of the isotope composition of proteins and peptides.It
offers some important advantages, including the ability to detect peptides
and proteins of low quantity (subnanomolar), and to analyze proteins,
protein-proteincomplexes andprotein-nucleicacidcomplexeswith
molecular weights greater than 300,000 Da (Gale 1995).In addition, MS
can distinguish populations of protein molecules that differ in molecular
weight (Miranker, Robinson et al. 1993; Arrington 1999).Recently, it has
been demonstrated that MS can provide amide site-specific information
about H/D exchange in cytochrome c (Deng 1999) and thioredoxin (Kim
2001).
In ESI-MS, electrospray serves as an ionization source as well as an
atmospheric pressure liquid inlet system for a mass spectrometer.The
sample solution is sprayed through a capillary that is charged with high
electrical potential (3-5 kV), yielding a mist of droplets mixed with vapor at
atmospheric pressure. Through the vaporization of solvent, the density of
electrical charge on the droplets increases until multiply charged ions form.
When multiply charged ions are formed, the apparent mass of an ion is
much smaller than its true mass (m/z < m when z > 1). The ESI technique
has found wide application in the analysis of proteins (Przybyski 1996),
nucleic acids (Przybyski 1995), lipids (Murphy 2001) and noncovalently
associated biomolecules (Gale 1995).26
When applied to proteins, ESI-MS produces a series of charged
ions. Generally, ESI mass spectra show a steady increase of these "charge
states" for proteins with increasing molecular weights.The number of
charged groups in solution has been found to be a determining factor for
the maximum number of charges on macromolecular ions. Many ESI-MS
experiments are carried out in acidic solutions, the distribution of charge
states may be attributed to the accessibility of basic amino acid residues for
protonation.Significant shifts of the ion distribution have been observed
from a comparison of mass spectra of the native proteins and the disulfide
bond reduced proteins (Loo 1990; Winger 1992).These studies have
shown that the mass spectra obtained for the disulfide-bonded proteins
favored substantially lower charge states than unfolded proteins in which
the disulfide bonds have been reduced. Chowdhury, Katta and Chait have
investigated electrosprayed cytochrome c as a function of solution pH
(Chowdhury 1990). They found that as the solution pH decreased and the
protein became unfolded, the distribution shifted from lower to higher
charges. Other factors such as temperature, solvent composition and ionic
strength, which lead to protein unfolding, can also influence protein
conformation in solution. Loo examined the changes in ESI charge states
for lyzozyme that was observed upon varying the fraction of several organic
solvents (Loo 1991).When the fraction of organic solvent increased, a27
shift to higher charge states was found indicating that the protein became
denatured in solution. In these cases, the three dimensional conformations
in solution are reflected in the structures of the gas-phase molecular ions.
There is also evidence suggesting that gas phase protein ions retain the
distribution of conformations that are present in solution (Loo 1994). The
evidence indicates that both the properties of the solution and the nature of
the gas phase ions can influence the ion structures in the final stages of
ESI.
Most H/D exchange studies used to probe protein conformations
have been carried out in solution (Smith 1994).Recently, H/D exchange
studies were used to probe gas phase ion conformations (Suckau 1993;
Mc Lafferty 1998).Mc Lafferty and co-workers used fourier transform ion
cyclotron resonance (FT-ICR) MS to investigate the conformations of
cytochrome c.In their experiment, the trapped ions were exposed to dilute
concentrations of D20 vapor and exchange was monitored for extended
time periods (Suckau 1993). Under these conditions, cyt c was found to
exist as multiple conformational states that were stable for hours, while in
solution H/D exchange of cyt c involved rapid equilibration among the
conformers. Comparison of the H/D exchange data between the solution
and gas phases should provide information on the role of water in protein28
structures, particularly where conformational changes take place as in
folding pathways.
Because electrospray ionization is a soft ionization method, it does
not produce fragment ions as readily as some other ionization techniques
do.Consequently, various tandem mass spectrometry techniques have
been developed to provide fragment ions,including collision induced
dissociation (CID) (Loo 1988), infrared multiphoton dissociation (IRMPD)
(Little 1994), blackbody infrared dissociation (BIRD) (Price 1996), surface
induced dissociation (SID) (Chorush 1995), inelastic electron collision
(electron impact excitation of ions from organics, EIEIO) (Wang 1990), and
electron capture dissociation (ECD) (Zubarev 2000).
During CID experiments, precursor ions are selectedin MS1,
dissociated by collision activation in a region between MS1 and MS2, and
scanned in MS2 (Figure 10).CID Celli
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Figure 10. Collision induced dissociation used to identify fragment ions.
Peptides are fragmented along the backbone in specific places, yielding
diagnostic ion series such as An, Cn, Xn, and Z,, (Figure 11).An
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Figure 11. Fragment ions resulted from cleavage of peptide backbones.
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The number of amides undergoing deuterium exchange in a protein
or peptide can be calculated by subtracting the m/z value of the ion peak in
the protonated form from the m/z value of the corresponding ion peak in the
deuterated form and multiplied by the appropriate charge state.At
individual amino acid residues, the deuterium content is obtained by
comparing the b and the y ions in the deuterated and the nondeuterated
forms.31
Although similar analysis of the y ions often yield deuterium levels
consistent with that found using the b ions, there are discrepancies
suggesting that intramolecular H/D scrambling may occur during CID
experiments for the y ions (Deng 1999).In the formation of y ions, the
amide bond is cleaved and two hydrogen atoms are transferred to the C-
terminal fragment (Figure 12).
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Figure 12. Proposed mechanisms for the formation of b and y ions.32
One of these hydrogens presumably is from the protonating solvent and
would therefore be expected to be a deuterium atom. The other hydrogen
comes from an amide hydrogen attached to the N-terminal side of the
cleavage site (Kenny 1992). This may lead to local scrambling of deuterium
label.In contrast, the formation of b ions does not involve the transfer of
any ambiguous hydrogen (Anderegg 1994). Thus, only b ions are used for
studying amide site-specific deuterium exchange. There is evidence that
electron capture dissociation (ECD) can fragment peptides into a series of c
and z ions, which may also be appropriate for studying site-specific H/D
exchange.However, fragmentation by ECD alone yields sequence
information only for the terminal region peptides.
There are various methods for introducing samples into the ESI-MS:
continuous flow infusion and on line separation systems such as liquid
chromatography (LC) and capillary electrophoresis (CE).In H/D exchange
experiments, the deuterium contents of proteins or peptides are often
determined by LC-ESI-MS.During chromatography, deuterium can
undergo back-exchange with protons from the HPLC solvent. Several
experimental procedures can be adopted to minimize this back exchange.
First, the pH and the temperature of the protein solution can be adjusted so
that NH exchange rate is at a minimum (pH 2.5 and 0°C).Second, the
HPLC injector and the column can be submerged in ice/water slurry, and33
thetransfersyringepre-cooledonicebeforeuse. Third,
chromatography can be optimized for speed rather than resolution. Under
these conditions, model studies have shown that the half-life for isotopic
exchange at peptide amide linkages is 30-120 min (Bai 1993; Smith 1998).
To adjust for any unavoidable deuterium loss during analysis, a
completely deuterated protein sample (100%) and an unlabeled protein
sample (0%) are used as reference points (Zhang and Smith 1993). The
deuterium content of partially deuterated peptides can be obtained from the
following expression:
D = [(m-mo%)/(mi00%- mo%)] x N Equation 6
where D is the deuterium content in a particular peptide and mm, m, and
m100% are the average molecular weights of the same peptide in the zero-
time controlpartially deuterated sample and fully deuterated control
respectively.N is the total number of peptide amide hydrogens in the
peptide.
It should be noted that Matrix Assisted Laser Desorption/lonization
Time-of-Flight (MALDI-TOF) mass spectrometry has been successfully
used for analyzing H/D exchange in protein complexes (Mandell 1998;
Mandell 1998).34
1.5Research goals
rhm-CSFO represents an excellent model system for studying
disulfide bond formation during protein folding because the assembly of its
monomeric subunits and the maturation of its biological activity dependon
the progressive formation of the correct disulfide structure during in vitro
folding (Glocker, Arbogast et al. 1994). The folding of rhm-CSFI3can be
studied by isolating various disulfide-bonded species during reductive
unfolding and oxidative folding.Furthermore, the intermediates can be
structurally and energetically characterized and their locationson the
unfolding or folding pathways defined.Knowledge obtained from these
studies can be potentially useful in understanding the roles of disulfide bond
formation during protein folding in general.
The specific goals of this project were to (1) selectivelyremove
disulfide bonds by chemical reduction, characterize the structures of the
protein derivatives, and access the bioactivity of the alteredprotein
structures; (2) investigate the roles of specific disulfide bondson protein
folding; and (3) identify the intermediates in the oxidative foldingpathways
and their rates of formation and decomposition.In this project, H/D
exchange was used to identify changes in relative solventaccessibility,
which was related to structural changesas a result of disulfide bond35
modifications. H/D and D/H exchange pulsed labeling experiments were
used to detect the presence of transient intermediates during protein
folding.ESI-MS was used to elucidate protein structures, identify protein
modification sites, and analyze hydrogen deuterium exchange data.36
2 Structural Comparison of Recombinant Human Macrophage Colony
Stimulating Factor 13 (rhm-CSFI3) and Its Derivative Using Hydrogen
Deuterium Exchange and Electrospray Ionization Mass Spectrometry
2.1Abstract
Hydrogen deuterium exchange, monitored by electrospray ionization
mass spectrometry, has been employed to characterize structural features
of a derivative of recombinant human macrophage colony stimulating factor
beta(rhm-CSF13)inwhichtwooftheninedisulfidebridges
(Cys157/Cys159-Cys'157/Cys'159) were selectively reduced and alkylated.
Removal of these two disulfide bridges did not affect the biological activity
of the protein.Similarities between CD and fluorescence spectra for rhm-
CSF13 and its derivative indicate that removing the disulfide bonds did not
stronglyaltertheoverallthree-dimensionalstructureofrhm-CSF13.
However, differences between deuterium exchange data of the intact
proteins indicate that more NHs underwent fast deuterium exchange in the
derivative than in rhm-CSF13. Regions located near the disulfide bond
removal site were shown to exhibit faster deuterium exchange behavior in
the derivative than in rhm-CSF13.37
2.2Introduction
Correctly folded protein is fundamental in the mechanism and control
of a wide range of cellular processes. A thorough understanding of the
complex process of protein folding requires the identificationof the
cooperative interactions among various folding events. This is intrinsically
difficult because these events take place quickly and the transient
intermediates cannot be readily obtained.However, in disulfide-coupled
folding processes, folding intermediates can be isolated by selective
reduction of disulfide bonds followed by alkylation of free cysteine residues.
In this way, intermediates can be structurally characterized using a variety
of physical techniques such as X-ray crystallography, NMR, CD and
fluorescence spectroscopy.Recent developments combining hydrogen
deuterium exchange and electrospray ionization mass spectrometry (H/D
ESI-MS) has provided an additional tool for the characterization of protein-
folding intermediates (Zhang and Smith 1993).Itisnon-perturbing,
sensitive and offerssufficientstructural and temporalresolutionfor
identifying conformational changes resulting from ligand binding (Kragelund
1995; Wang 1997) and chemical modification (Resing 1998).
Macrophage colony-stimulating factor is the principle regulator of
monocyte and macrophage development (Stanley 1997). The interaction of38
m-CSF and its receptor, m-CSFR, induces proliferation of fibroblasts, or
ofhematopoieticcells,whichresultsindifferentiationtowards the
monocyte/macrophage lineage of myeloid progenitor cell lines (Bourette
2000). The recombinant human m-CSFI3, was expressed from Escherichia
coil as a truncated form (aa 4-218, 49KDa) of one of the three human cDNA
clones (Pandit 1992).It is biologically active only in the homo-dimeric form
that is maintained by three inter- and six intra-molecular disulfide bridges
(Figure 4).The systematic reduction of these disulfide bonds in rhm-
CSFI3 can reveal the specific role that each disulfide bond plays in
maintaining the overall protein structural integrity as well as the biological
activity. The disulfide bridges were assigned using enzymatic digestion and
fast atom bombardment mass spectrometry (Glocker, Arbogast et al. 1993).
Two intermolecular disulfide bonds in the C-terminal region were found
between Cys157/159 and Cys'157/159.It is unclear whether Cys157 forms
a disulfide bond with Cys'157 or Cys'159.Nonetheless, it is evident that
these cysteine residues form symmetrical disulfide bonds that are in close
proximity in the three-dimensional space. The present study focuses on the
effect of removing Cys157/159-Cys'157/159 on the three-dimensional
structure of rhm-CS93 using the H/D-ESI-MS approach.39
2.3Results
2.3.1 Chemical modification.
Mild reduction at pH 3.5 was applied to rhM-CSF6 to achieve
selective reduction of Cys157/159-Cys'157/159. The low pH was used in
order to avoid disulfide bond scrambling. The reduced cysteine thiols were
then alkylated with CDAP at pH 3.5. In contrast to what was reported in the
literature (Wu 1997), TCEP was found to interfere with cyanylation and
must be removed prior to the addition of CDAP to the partially reduced
protein. Chromatographic separation by RP-HPLC provided a homogenous
species whose molecular weight was determined to be 49,130 Da (Figure
13). The partially reduced cyanylated protein has a MW 100.6 Da greater
incomparisonto rhM-CSF6 (49,029.4Da),a mass increasethat
corresponds to an incorporation of 4 cyano groups.The charge state
distributions in ESI-MS for the native and the CN157'159-modified rhm-CSF6
appear to be different (Figure 13).(A)
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Figure 13. Mass spectra of rhm-CSFI3 (A) and CN157.159-modified rhm-
CSFI3 (B).
The native protein shows a distribution of charge states ranging from 28+ to
20+, with 22+ being the most intense peak.In contrast, the modified
protein gives a distribution with higher charge states and a maximum
around 32+.41
2.3.2 Identification of modification sites.
To identify the sites of cyanylation, the modified protein was
subjected to base hydrolysis (Wu 1997) which cleaved the N-terminal
peptide bonds of the cyanylated cysteinyl residues and formed a cyclic ring
structure. After cleavage at the cyanylated cysteinyl residues, the truncated
peptide chains still linked by the remaining disulfide bonds were reduced by
excess TCEP. The mass spectra indicated the presence of polypeptides
6,517.5 Da and 17840.8 Da (Figure 14).42
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Figure 14. Mass spectra for protein intermediates in the reductive unfolding
pathway.(A) Mass spectrum of polypeptide aa 4-156 (MW 17840. 8
Da) after base hydrolysis and reduction.(B) Mass spectrum of
polypeptideaa4-156aftercompletereductionand
carboxyamidomethylation (MW 18239.4 Da, CAM7,31,48,90,102,139,146).
After complete reduction with TCEP, the nascent thio groups were
alkylated with iodoacetamide.The mass spectra indicated there were
species with molecular weights 6,518 Da and 18,239.4 Da (Figure 14). By
comparing the predicted and experimental masses, the polypeptide with
mass of 6,517 Da was identified as aa 159-221 with Cys159 cyanylated.
The polypeptide with mass 17,840.8 Da was identified as aa 4-156 with no43
alkylation, and the polypeptide with mass 18,239.4 was determined to be
aa 4-156 with 7 cysteinyl residues carboxyamidomethylated.Peptide
fragment aa 157-158 was not found; however, cyanylation must have taken
place at Cys 157 based on the MW of the intact, modified protein. These
results indicated that Cys 157 and 159 had been cyanylated and that the
disulfide bonds linking these cysteinyl residues in the dimer had been
reduced. Thetrypticdigestionofthecompletelyreducedand
carboxyamidomethylated protein further verified this conclusion.CID
MS/MS experiments confirmed that Cys 157 and Cys 159 were the only
cyanylatedcysteinylresiduesandallothercysteineswere
carboxyamidomethylated.
2.3.3 Biological activity.
M-CSF-dependent NFS-60 assay was used to compare the specific
biological activity of the modified protein to that of rhm-CSFO. The doubling
time of cell growth that is stimulated by CN157159-modified rhm-CSFO was
identical to the doubling time of cell culture stimulated by rhm-CSFp (Figure
15).Thus, the removal of Cys157/159-Cys'157/159 did not affect the
biological activity of rhm-CSFp.1000000
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Figure 15. Biological activity of CN157'159-modified rhm-CSFI3 and rhm-CSF8
determined by M-NFS-60 cell assay. Doubling time was determined to
be 14.9 hr rhm-CSF13 and 15.08 hr for CN157.159-modified rhm-CS93.
2.3.4 Circular and fluorescence spectroscopy.
The CD spectrumforCN157'159-modifiedrhm-CS93closely
resembles that of rhm-CSFI3 which exhibits a positive maximum near
190nm and a negative minimum near 208nm (Figure 16).These CD
spectra reflect that the structuralintegrity of the a-helical bundle is45
maintained in the CN157159-modified rhm-CSF6. Fluorescence emission
spectra obtained by excitation at 280nm and 290nm for CN157'159-rhm-
CSFO essentiallyoverlapwiththoseforrhm-CSF8 (Figure17)
demonstratinglittlestructuralchangeresultedfromthechemical
modification.
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Figure 16. CD spectra of rhm-CS93 and CN157,159-modified rhm-CSF13 in
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Figure 17. Fluorescence emission spectra of rhm-CS93 and CN157'159-
modified rhm-CS93 in 10mM ammonium phosphate buffer at pH 6.8.
2.3.5 Hydrogen deuterium exchange.
To probedetailedstructuralchanges causedbyremoving
Cys157/159-Cys'157/159,bothCN157'159-modifiedrhm-CS93 and rhm-
CS93 were incubated in D20 for 4 s to 70 hr. The deuterium level in both
proteins increased with incubation time until approximately 320 of the NHs
had been replaced with deuterium (Figure 18).320
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Figure 18. Dependence of deuterium in CN157"59-modified rhm-CSFI3 and
rhm-CSF13 on the exchange time (4s to 70h).
The change in deuterium level with incubation time was fitted to
equation 2 to estimate rate constants for isotope exchange at peptide
amide linkages (Table1).These data reveal that the removal of
Cys157/159-Cys'157/159 resulted in an increase of 19 fast exchanging NHs
(k>10min-1), a decrease of 9 fast exchanging NHs (k--1 min-1) anda
decrease of 5 slow exchanging NHs (k-0.01min-1). The shift in population
in these rate categories indicates a general increase in the amount of48
deuterium exchange as the disulfide bonds are removed resulting in a
looser three-dimensional structure of the protein.
Table 1. Distribution of rate constants for isotope exchange at peptide
amide linkages in rhm-CS93 and CN157159-modified rhm-CS93.
Number of Amide Hydrogens
k > 10 min-1k -1 min-1 k - 0.01 min-1k < 0.001 min-1
rhm-CS93153.34+5.4057.25+5.9050.72+4.6 142.71+15.9
CN157'159-
rhm-CSF13172.6+4.0 47.4+3.9 45.9+2.7 138.1+10.6
To locate the specific regions that became more flexible after the
removal of Cys157/159-Cys'157/159, deuterium-labeled CN157'159-modified
rhm -CSFI3 and rhm-CS93 were digested by pepsinpriorto mass
spectrometric analysis. Peptic digestion produced 45 and 38 overlapping
peptides which cover >90% of the backbone in CN157'159-modified rhm-
CS93 and rhm-CS93 respectively. The deuterium levels in each peptide
were determined by analyzing the doubly charged fragments using CID
MS/MS. The change in deuterium levels with incubation time was fitted to
equation 2 to estimate rate constants for individual peptides (Table 2).49
Table 2. Distribution of rate constants for isotope exchange at peptide
amide bonds in rhm-CSFO (N) and CN157'159-modified rhm-CSFI3 (M) (k,
min-1).
Segment Fastest
(>10)
Fast Slow Slowest
(<0.001)
4-19 N 10.27 0.350 (0.15)0.71 (0.024) 3.67
M 10.35 0.63 (0.04)0.70 (0.008) 3.32
37-55 5.81 2.38 (0.39)3.25 (0.035) 5.56
5.84 3.31 (0.29)2.62 (0.018) 5.23
56-62 0.65 1.33 (4.76) 1.15 (0.113) 2.87
0.38 1.50 (0.54) 1.22 (0.004) 2.90
63-76 5.18 1.24 (0.22)2.98 (0.031) 2.60
4.80 1.37 (0.74)3.54 (0.058) 2.29
77-82 1.31 0 1.22 (0.015) 2.47
0.86 0.63 (1.47) 1.16 (0.011) 2.35
83-105 5.33 5.03 (0.44)4.95 (0.016) 5.69
5.19 5.75 (0.45)5.30 (0.009) 4.76
106-113 1.73 0.80 (0.37) 1.18 (0.030) 2.29
1.54 0.86 (0.68)0.76 (0.098) 2.84
114-143 11.7 6.02 (0.46)2.92 (0.014) 8.36
11.68 5.8 (0.5) 4.09 (0.013) 7.43
151-189 25.11 0.27 (0.50)0.22 (0.006) 4.4
161-189 22.15 0.37 (1.00)0.23 (0.002) 0
22.30 0.85 (1.88)0.30 (0.018) 0
151-160 6.30 0.37 (1.35)0.51 (0.015) 0.82
190-221 24.56 0.24 (0.36)0.48 (0.001) 2.72
25.94 1.07 (1.35) 0.11 (0.10) 0.88
Local structural differences between the two proteins can be
identifiedby comparing deuteriumlevels and kineticratesfor the
corresponding peptides. As seen with whole proteins, most of the peptides
exhibit fairly similar deuterium exchange behavior. This is particularly true
in the N-terminal region (aa4-149) where exchange kinetics of peptides50
CN157'159-modified rhm-CSF13 are identical to those in rhm-CSF13. The
deuterium level found in the segment covering residues 4-19 (Figure 19) as
a function of the time the intact proteins were incubated in D20 was fitted to
a series of exponential functions.
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Figure 19. The deuterium levels found in segments covering as 4-19 in
rhm-CSF13 and CN157'159-modified rhm-CSFP are shown as a function
of the exchange time (4s to 40h).51
The results indicate that in rhm-CSF8, 10.27 amide hydrogens in the
segment 4-19 have isotope exchange rate constants greater than 10min-1,
0.35 amide hydrogens of 0.15 min-1, 0.71 amide hydrogens of 0.024min-1,
and 3.67 amide hydrogens of exchange rate constants smaller than
0.001min-1 (Table 2).In comparison, the same segment derived from
CN157'159-modified rhm-CSFl3 had 10.35 amide hydrogens which exchanged
with rates greater than 10min-1, 0.63 at 0.04min-1, 0.7 at 0.008min-1, and
3.32 with rate constants that were less than 0.001min-1.The deuterium
exchange rates are independent of whether disulfide bonds linking
Cys157/159-Cys'157/159 are present.Similar analyses were done for
other segments covering residues 4 to 153 derived from both proteins.
Since no difference in amide hydrogen exchange rates was detected in this
region, these results suggest that removing these disulfide bonds has little
effect on the structure in the N-terminal region.
The C-terminal region of CN157159-modified rhm-CSF8 (aa151-221)
showed a higher population of very fast and fast exchanging NHs than in
rhm-CSF8. This is not surprising because Cys157, 159 are located in this
area.The deuterium level found in the segment derived from the N-
terminal side of Cys157,159 (aa 151-160) in CN157'159-rhm-CSF13 was fitted
to equation 2.In this segment, 6.3 NHs underwent deuterium exchange
with rate constants greater than 10min-1, 0.37 NHs with k of 1.35min-1 and52
0.51 NHs with k of 0.015min-1 (Table 2).The remaining 0.82 amide
hydrogens had deuterium exchange rate constants less than 0.001min-1.
This exact peptide was not found in the peptic digest of rhm-CSF13.
However, information on deuterium levels in this segment can be deduced
by analyzing two segments covering residues 151-189 and 161-189. The
difference between deuteriumlevelsfor these two segments yields
information regarding the segment aa151-160 in rhm-CSFO. Results from
such a comparison (Table 3) show that in the segment aa151-160 of rhm-
CSF13, 2.23 NHs underwent very fast or fast exchange with exchange rate
constants greater than 0.5min-1 and 4.4 amide hydrogen exchanged at rate
constants less than 0.001min-1.
Table 3. Distribution of rate constants for isotope exchange at peptide
amide bonds in rhm-CSFO and CN157'159-modified rhm-CSFI3 (k,
Very fast Fast Slow Very slow
rhm -CSF3
151-189
25.11 (>10)0.27 (0.50)0.22 (0.006) 4.4 (<0.001)
rhmCSFI3
161-189
22.15 (>10)0.37 (1.00)0.23 (0.002) 0 (<0.001)
rhm -CSFI3
151-160
2.96 (>10) 0 (-1) 0 (0.002) 4.4 (<0.001)
modified
151-160
6.30 (>10)0.37 (1.35)0.51 (0.015)0.82 (<0.001)
Difference3.34 (>10) 0.37 (-1) 0.51 (-0.01)-3.58 (<0.001)53
Itissignificant that the deuterium exchange patterninthis
segment of rhm-CSF13 is different from the same segment derived from
CN157159-rhm-CSFO. Mostimportantly,4 amide hydrogens which
exchanged with small rate constants in rhm-CSFP became large in the
modified protein, thereby showing that local structural changes resulted
from removing Cys157/159-Cys'157/159. The deuterium level data found in
the segment residues 191-221 (Figure 20) was fitted to equation 2.
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Figure 20. Deuterium levels found in segments covering aa190-221 in rhm-
CSF13 and CN157'159-modified rhm-CSFE3 are shown as a function of the
exchange time (4s to 40h).54
Data analysis shows that in the segment derived from the modified
protein, 25.94 amide hydrogens have isotope exchange rate constants
greater than 10min-1, 1.07 amide hydrogens with k of 1.35 min-1, 0.11 amide
hydrogens with k of 0.01min-1, and 0.88 amide hydrogens with exchange
rate constants smaller than 0.001min-1.In contrast, in the same segment
derived from rhm-CSF13, 24.56 amide hydrogens exchanged with rate
constants greater than 10min-1, 0.24 at 0.36min-1, 0.48 at 0.001min-1, and
2.72 exchanged with rate constants smaller than 0.001min-1 (Table 2).
Clearly, the deuterium levels in the segment of the modified protein are
greater than in rhm-CS93, suggesting that at least some part of the
structure of the former is more open. However, the difference is quite small
which indicates that the overall conformation in this area is not significantly
different for the two proteins. Such analysis for other peptides covering as
151-221 shows similar results: nearly all NHs in this region underwent fast
isotope exchange in both proteins, suggesting very little protection against
deuterium exchange.In addition, peptides derived from the modified
protein consist of more fast exchanging NHs than those from rhm-CS93,
indicating that the C-terminal region in the modified protein is more flexible
than in rhm-CSF13.
To demonstrate a possible correlation between amide hydrogen
exchange rates and intramolecular bonding NHs in a helices and f3 sheets,55
the number of peptide amide hydrogens participatingin hydrogen
bonding was estimated for each segment of rhm-CS93 using available x-
ray data. These results (Table 4) expressed as the percent of hydrogen
bonding Hs in each segment are the percent of NHs with exchange rate
constants less than 0.01 mirll.It is evident that the slowest exchanging
amide hydrogens are located in segments in which the amide hydrogens
participate in intramolecular hydrogen bonding.
Table 4. Percent of slow exchanging (k<0.05min-1) amide hydrogens in
rhm-CS93 and CN157'159-modified rhm-CS93 compared with percent of
hydrogen bonding amide hydrogens identified by X-ray crystal data of
m-CSFa.
Segment rhm-CSFI3 CN157'159-rhm-CS93 a or (3 (%)
4-19 29.2 31.2 46.7
37-55 51.8 46.2 58.8
56-62 67.0 52.0 100
63-76 46.5 56.9 25.0
77-82 73.8 70.2 100
83-105 48.4 45.7 36.4
106-113 57.8 60.0 100
114-128 71.4 75.2 100
114-143 59.7 59.7 69.0
2.4Discussion
The removal of disulfide bonds linked by Cys157/159-Cys'157/159
was shown not to affect the biologicalactivity.The overall three-56
dimensional structure of the protein was not significantly affected as
demonstrated by CD and fluorescence spectroscopy.However, some
structural variations between the native and the modified rhm-CSF13 were
revealed by the charge state distributions in the ESI-MS spectra of the
intact proteins (Figure 13). The distribution of charge state centers on 21+
in native rhm-CSFI3 and 33+ in the modified protein. The difference of +12
in the dimeric proteins may be attributed to the accessibility of six additional
basic amino acid residues (K154,D156, Y161, K163,D169,176
,H) for protonation
as the surface area in the C-terminal region increased resulting from the
removal of Cys157/159-Cys'157/159.Hydrogen deuterium exchange
experiments also indicated observable structural changes that had taken
place upon the removal of Cys157/159-Cys'157/159.As a result of
disulfide bonds' removal, there is an increase of 19 fast exchanging NHs
(k>10min-1), a decrease of 9 fast exchanging NHs (k--1mir11) and a
decrease of 5 slow exchanging NHs (k-0.01min-1). The shift in population
in these rate categories indicates a general increase in the amount of
deuterium exchange as the disulfide bonds are removed and a less
compact regional three-dimensional structure of the protein resulted.As
demonstrated in this study, structural changes that are not readily detected
by optical methods can be identified and localized by ESI charge state
distribution in combination with hydrogen/deuterium exchange experiments.57
Detailed structural features of the C-terminal region of rhm-CS93
have not been revealed by x-ray crystallography.The present study
provides significant structural descriptions of this region. The similar CD
spectra indicate that the a-helical bundle core is not disturbed by the
removal of Cys157/159-Cys'157/159. The fluorescence data also indicates
little change as the disulfide bonds are removed.Interestingly, Trp191 is
located on the C-side of the disulfide bond removal site.Apparently, the
modification has no effect on the fluorescence property of this residue.
However, significant differences in deuterium exchange behavior of this
region have been revealed by hydrogen/deuterium exchange studies.
These data suggest that within the C-terminal region (aa151-221) there are
sub-regions that are affected to various degrees by the removal of
Cys157/159-Cys'157/159. Upon the removal of Cys157/159-Cys'157/159,
the sub-region that is on the N-side of the disulfide bond removal site
(aa151-159) is shown to exhibit more significant exchange behavior than
the sub-region on the C-side (aa160-221).It is possible that Cys157/159-
Cys'157/159 are placed relatively close to the protein a-helical core (Figure
4). Upon the removal of these disulfide bonds, the sub-region (aa151-159)
whose structure maintained by Cys157/159-Cys'157/159 becomes flexible
and exhibits different deuterium exchange behavior. The sub-region that is
already flexible (aa160-221) prior to the chemical modificationis not58
strongly affected by the modification as supported by the unchanged
fluorescence property of Trp191 as well as the peptide deuterium exchange
data.
Hydrogen isotope exchange kinetics for the intact protein and
individual peptides combine to provide a detailed structural characterization.
Fitting of global exchange data separates amide hydrogens into groups with
different exchange rates.In contrast, the summation of NHs within the
same exchanging group of peptides covering 90% of the backbone does
not add up to the same number provided by global exchange data. This is
partly because peptides covering 10% of backbone could not be identified
in the peptic digest.More importantly, the N-terminal NH from every
peptide was lost during the HPLC step.In some cases, depending on the
sequence of the peptide, the NH from the amino acid second from the N-
terminus was also lost (Engen, Gmeiner et al. 1999).In contrast, in the
intact protein, only the NH at the N-terminus was lost.Irrespective of the
more significant loss of labeling determined by peptide analysis, deuterium
exchange rate data on the peptide level can locate the regions where the
three-dimensional structure has changed. Even though this approach can
only estimate the number of NHs within a given range of exchange kinetics,
it is useful in the identification of structural alteration caused by chemical
modification, mutation and ligand binding. A similar approach that focuses59
on the CID MS/MS experiment can be used to estimate deuterium levels
at individual peptide bonds (Deng 1999).In this way, more detailed
structural information can be obtained for large proteins and protein
complexes.
2.5Conclusion
By cDNA cloning, another form of m-CSF, named m-CSFa can be
obtained.In the membrane-bound form, m-CSFa and p are identical in
their N-and C-terminal regions, but m-CSF13 contains inserts at residue 149
as a result of alternative mRNA processing (Pandit 1992). The N-terminus
(aa1-149) contains the receptor-binding domain, and the C-terminus
contains a transmembrane region that is believed to anchor m-CSF in an
active, cell-associated form. It has been proposed that m-CSF is expressed
in variable lengths from a single gene in order to provide membrane-
associated m-CSF with variable length spacers to allow direct contact with
receptors on neighboring cells (Cerretti 1988).In the membrane-bound
form of m- CSFf3, as 150-221 is part of the length spacer that connects the
signal sequence (N-terminus) to the trans-membrane domain (C-terminus).
This agrees with previous experiments which indicated that the C-terminal60
region in m -CSFI3 (aa150-221) is not important for the protein's biological
activity (Pandit 1992).
A previous study reports the characterization of a stable dimeric
intermediate isolated from the in vitro folding reaction of rhm -CSFI3 (Maier,
1999). This refolding intermediate contains seven disulfide bonds and four
carboxyamidomethylated cysteinyl residues.In addition, its charge state
distribution closely resembles that of the CN157'159-modified rhm-CSFf3
indicating they may be the same intermediate that exists in both the folding
and unfolding pathways.
The present study suggests that Cys157/159-Cys'157/159 play a
minor role in maintaining the three-dimensional structure in the C-terminus
of the protein. An important question arises: do these disulfide bonds play
any role in the folding pathway of rhm-CS93? Most likely, these disulfide
bonds help to stabilize the folded structure rather than introducing structure
into the polypeptide chain as the protein folds.It is possible that they may
provide additional stability for the proper protein conformation in the final
stage of folding.61
2.6Materials and methods
2.6.1Materials.
Purified, biologically active rhm-CSF13 was provided by Dr. C. Cogwill
(Chiron Corp. Emeryville, CA).NFS-60 cell line was provided by Dr. J.
Weaver (Chiron Corp.Emeryville, CA).Tris(2-carboxyethyl)phosphine
(TCEP) and immobolized pepsin were obtained from Pierce (Rockford, IL).
1-cyano-4-dimethylaminopyridinium fluoroborate (CDAP) was obtained from
Sigma Chemicals.Modified trypsin was purchased from Promega
(Madison, WI). Deuterium oxide and urea-d4 were obtained from Aldrich
Chemical Co. (Milwaukee, WI).All other chemicals and reagents were of
the highest grade commercially available.
2.6.2 Partial reduction of rhM-CSF/3.
The freshly dissolved rhM -CSFJ (12nmol) was solubilized in 300 ill
of 20 mM ammonium acetate buffer (pH 3.5) containing 1 mM EDTA.
Partial reduction of rhM -CSFf was initiated by adding 0.05 equivalent of62
TCEP of total cysteine content and followed by incubation at room
temperature for 5 hrs.After TCEP was removed by centrifugal filtration
using ultrafree MC filters with a 5,000 Da molecular mass cutoff (Millipore),
a 25-fold molar excess of CDAP solution over the cysteine content was
added to the partially reduced protein mixture. Cyanylation of the sulfhydryl
groups was done at room temperature for 10 min.CDAP was then
removed by centrifugal filtration.The reduced, cyanylated protein was
purified by reversed phase high performance liquid chromatography (HPLC)
on a Vydac C4 TP214 column (300A, 5 gm, 4.6X250 mm, 1 mVmin flow
rate) employing a binary linear gradient elution with 0.1% trifluroacetic acid
(TFA) as solvent A and acetonitrile (ACN) containing 0.09% trifluroacetic
acid as solvent B.The proteins were eluted using a 60 min 44-54% B
gradient. Protein fractions were collected manually and lyophilized.
2.6.3 Identification of reduced disulfide bonds.
The lyophilized modified rhM-CSFI3 was dissolved in 30 RI of 6M
guanidine-HCI in 1 M NH4OH (pH 11.3). Cleavage of the peptide chain was
performed by adding 30 gl of 1 M NH4OH (pH 11.5) followed by incubation
at room temperature for 1 hr. Excess ammonia was removed in a vacuum63
centrifuge. Truncated peptides containing residual disulfide bonds were
completely reduced by reacting with 250 gl of 7.2 mM TCEP solution at
37°C for 30 min (pH 8.5). To the completely reduced protein mixture, 8 p,I of
iodoacetamide (20mg/mI) in 0.1M TrisCl at pH 8.5 was added and the
mixture was incubated for 1 hr at room temperature. The reaction mixture
was subjected to mass spectrometric analysis utilizing a Shimadzu HPLC
equipped with two LC-10AD pumps coupled to a PE-Sciex API III triple
quadrupole mass spectrometer equippedwithanebulizer-assisted
electrospray source.A capillary column packed with Vydac C4 TP214
material (5 pm particle size, 300 A pore size, 20 gUmin flow rate) was
used. The binary gradient elution included 0.05%TFA as solvent A and
ACN containing 0.05% TFA as solvent B. The proteins were eluted using a
8min 10-90% B gradient.MS spectra were analyzed using PE Sciex
software (Mac Spec and BioSpec).
The carboxyamidomethylated protein mixture was subjected to
tryptic digestion by reacting with 2 jig of trypsin in 100 IA of 0.1 M tris buffer
(pH 7) containing 1 mM CaCl2. The tryptic digest mixture was analyzed
using a Waters HPLC equipped with two pumps coupled to a Finnigan
quadrupole ion-trap mass spectrometer. A capillary column packed with
C18 Luna material (5 p.m particle size, 300 A pore size, 5 jilinnin flow rate)
was used.The identities of tryptic peptides were determined by collision-64
induced dissociation (CID) experiments.The biological activity of the
modified protein was determined using m-CSF dependent NSF-60 cell
culture assay (Nakoinz 1990).
2.6.4 Circular dichroism and fluorescence spectroscopy.
CD spectra were obtained using a Jasco J720 spectropolarimeter
(Jasco Inc., Easton, MD) over the range of 185-310nm in a cylindrical 1-cm
path length quartz cuvette and with a bandwidth of 2nm and a scan speed
of 10nm/min. Fluorescence data was acquired on a 8100C fluorescence
spectrometer (SLM Instruments Inc., Urbana-Champaign, IL) with 8nm
emission and excitation slit widths using a square 0.5 cm path length quartz
cuvette.
Fluorescence was measured at excitation wavelengths of 280nm
and 290nm and expressed as a ratio of emission intensity to reference
emission intensity.65
2.6.5 Deuterium exchange-in experiments.
The lyophilized CN157'159-rhm-CSF13 (250 lig) was dissolved in 10 jil
of 10 mM ammonium phosphate buffer (pH 6.8) containing 1 mM EDTA.
In-exchange was initiated by diluting the protein solution 20-fold with 10 mM
ammonium phosphate/D20 buffer (pH 6.8) containing 1 mM EDTA. At each
time point, 10 mg of protein sample was removed from the labeling solution
and diluted 1:1 with 0.1 M ammonium phosphate buffer (pH 2.3, 0°C, 1:1
D20/H20) to quench isotopic exchange. The samples were stored in liquid
N2 until analysis.Unlabeled protein (0% reference) was prepared by
dissolving the modified protein in 0.1 M ammonium phosphate buffer (pH
2.3, 0°C,1:1D20/H20).The completely deuterated protein (100%
reference) was prepared by incubating the modified protein in 8 M urea-d4/
D20 at 37°C for 6h.The same exchange procedure was applied to rhm-
CS93.
The deuterated protein samples were analyzed by LC-ESI-triple
quadrupole MS (PE-Sciex API 1111 using a self-packed C4 column (5 gm
particle size, 300 A pore size, 20 AL/min flow rate) and a binary gradient
elution involving 0.05% TFA as solvent A and ACN containing 0.05%TFA
as solvent B.After desalting at 10%B for 2min, the protein was eluted
using a 3 min 10-80% B program. The HPLC injector and the column were66
submerged in ice/water slurry, and the transfer syringe was rinsed with
D20 and pre-cooled on ice before use.MS spectra were analyzed by
BioSpec software.
The deuterated CN157'159-rhm-CSFI3 was digested by immobolized
pepsin (protein/enzyme = 1/2 (w/v)) in 0.1 M ammonium phosphate buffer
(pH 2.3, 0°C, 1:1 D20/H20) for 8min. The digest mixturewas analyzed
using LCQ-ESI-ion trap mass spectrometer using a C18 Luna column (5Jim
particle size, 100 A pore size, 15 gUmin flow rate) and 0.05%TFAas
solvent A and ACN containing 0.05% TFA as solvent B.After being
desalted for 2min, peptides were eluted using the followingprogram: 10-
20%B for 1min, 20-30%B for 1min, 30-45%B for 2min, 45-60%B for 1min,
60-90%B for 3min. To minimize deuterium back exchange, the injector and
the column were immersed in an ice/water bath, and the transfer syringe
was rinsed with D20 and cooled on ice before use.Due to the
compactness of the modified protein, this digest procedure resulted in only
57% coverage of the protein backbone.Consequently, the complete
digestion of the deuterated modified protein was obtained by incubating
deuterated protein with 0.1 M ammonium phosphate buffer (pH 2.3, 0°C,
1:1 D20/H20) containing 8 M urea-d4 and 1 M TCEP at 0°C for 5min priorto
pepsin digest.This procedure yielded 90% coverage of the entire
backbone but did not provide cyanylated peptides because TCEP reduced67
cyanylated cysteine residues.The peptides were identified by CID
experiments. The deuterated rhm-CSF13 was subjected to pepsin digestion
using the same procedure as described above.
2.6.6 Data analysis.
Because the HPLC elution was performed with protiated solvents, a
small number of deuteriums at the amide positions are lost.Corrections
were made for this deuterium loss using eq. 1 (Zhang and Smith 1993):
D = [(m-mo%)/(mio0%- mo %)] x N Equation 6
where D is the number of deuteriums present in a particular peptide
segment or protein after incubation in deuterated solvent, and m, m0%, and
mo% represent the average molecular weight of a peptide or protein
obtained for non-deuterated, partially deuterated and completely deuterated
samples, respectively.N is the total number of exchangeable amide
hydrogensinthe protein or the peptide ofinterest.The present
experiments yielded 10-20% back exchange in both proteins and peptides.68
Amide hydrogens undergo deuterium exchange atdifferentrates
depending on whether the hydrogens participate in intramolecular hydrogen
bonding, as well as on the extent to which the hydrogens are shielded from
the solvent.Exchange-in data for proteins and peptides can be analyzed
using eq. 2(Engen, Smithgall et al. 1997), which distinguishes amides
according to whether they are fast, intermediate, slow or non-exchanging:
n
D = N - I exp(-Icit) Equation 7
1
where D is the deuterium level found in a protein or peptide with N amide
linkages following incubation of the intact protein in the deuterated solvent
for time t and ki are the first order rate constants for isotopic exchange at
every amide linkage. Thus, higher-order structure, structural changes, and
structural dynamics of the protein that control exchange rate behaviorcan
be defined.Data fitting for deuterium exchange was accomplished using
Origin6.1 (Microcal Software, Inc).69
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3 Consequences of Removing Disulfide Bridges on Folding of
Recombinant Human Macrophage Colony Stimulating Factor Beta
3.1Abstract
Hydrogen exchange pulsed labeling, monitored by ESI-MS, has
been employed to study theinvitro folding of recombinant human
macrophage colony stimulating factor beta (rhm-CS93) and its derivative in
which two of the nine disulfide bridges (Cys157/Cys159-Cysi 57/Cysi 59)
were selectively reduced and alkylated. The overall folding kinetics of rhm-
CSF13 were very similar to those of CN157'159-modified rhm-CSFP. For both
proteins, a substantial amount of three-dimensional structure was formed
within 7.5 ms after folding was initiated.Little structural change was
detected when the folding time was extended to 48 hr.These data
indicated that the removal of Cys157/159-Cys'157/159 did not affect the
overall folding of rhm-CSF13 in the presence of seven native disulfide bonds.
KEY WORDS: hydrogen exchange pulsed labeling, quenched flow, rhm-
CSFI3, protein folding72
3.2Introduction
The processes by which proteins fold from unstructured polypeptides
into their unique native conformations have been an important topic for
structural biology research (Wedemeyer 2000).In proteins that contain
disulfide bonds, the proper formation of the disulfide bonds contributes
significantly to the stability of the native conformation and help direct protein
folding (Creighton 1993). The effects of disulfide bond formationon protein
folding have been investigated for several protein systems. For example,
Ey les et al observed that the disulfide bond Cys6-Cys127was crucial for
stabilizing the partially folded intermediates in lysozyme and that the
removal of this disulfide bond led to the disappearance ofan important
intermediate during folding (Ey les, Radford et al. 1994).Ruoppolo et al
observed that the removal of Cys58-Cys110 and Cys26-Cys84 hada
dramatic effect on the folding kinetics of RNase A (Ruoppolo 2000). These
authors suggested that the cysteine residues might workas internal
catalysts and promote shuffling of disulfides to accelerate isomerization
reactions in the establishment of the native conformation of RNase A.
Recombinant human macrophage colony stimulating factor beta isa
glycoprotein that stimulates the proliferation, differentiation and survival of
cells belonging to the monocyte-macrophage lineage both in vivo and in73
vitro (Stanley 1994).rhm -CSFI3 is a homodimer maintained by six
intramolecular and three intermolecular disulfide bridges (Figure 4). Two
intermolecular disulfide bonds (Cys157/159-Cys'157/159) are located in the
tail regions near the C-termini. A previous study showed that the removal
of these two disulfide bridges did not affect the biological activity of rhm-
CSFO nor did it strongly alter the overall three-dimensional structure of the
protein (Zhang 2001).However, the regions near the disulfide removal
sitesbecame moreaccessibletohydrogendeuteriumexchange,
suggesting a more flexible conformation. Therefore, these disulfide bonds
served to maintain the proper three-dimensional fold of the protein in the C-
terminal regions. An interesting question arises: do these disulfide bonds
play any role in the formation of the three-dimensional structure during rhm-
CSFO folding? The present study addresses this question by investigating
thefoldingkineticsofrhm-CSFI3 and CN157'159-modified rhm-CSFP
monitored by deuterium/hydrogen (D/H) exchange pulsed labeling.74
3.3Results and discussion
3.3.1Equilibrium unfolding by far-UV circular dichroism and fluorescence
spectroscopy.
The thermodynamic stabilities of rhm -CSFI3 and CN157'159- modified
rhm-CSFO were studied by equilibrium unfolding in urea, monitored by far-
UV CD spectroscopy.The degrees of unfolding for both proteins were
monitored by their ellipticity at 222 nm at 25°C (Figure 21).
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Figure 21. Equilibrium unfolding of CN157'159-modified rhm-CSFp and rhm-
CSFO studied by circular dichroism spectroscopy at 222 nm at 25°C.75
The denaturation curves for rhm-CSFp and CN157'159-modified rhm-CSFO
were essentially superimposable, suggesting that these proteins had similar
stabilities.Both proteins exhibited highly cooperative unfolding transitions
with an apparent lackof equilibriumunfoldingintermediates.The
dependence of AG° on the denaturant concentration for a system in which
only the folded and unfolded states were present at equilibrium was
analyzed by the following equation:
AG°[urea] = AG°[0] + m*c Equation 8
where AG°[urea] represents the free energy of unfolding at various urea
concentration, AG°[0] represents the free energy at zero concentration
urea, m measures the sensitivity of AG° on denaturant concentration, and c
represents urea concentration. This equation was used to fit the data from
the CD experiments, yielding AWriviCSF13= 23.01+2.75 kcaVmol, mmmcsFfi=
2.97+0.37 kcal/mol/M, AV)modified rlimCS93= 23.15+1.93 kcaVmol, and mmodified
rhrocsFp = -3.00+0.25kcaVmoVM. The equilibrium m-values for rhm-CSFO
and CN157'159-modified rhm-CSFp were nearly equivalent, suggesting that
both proteins exhibited similar sensitivities to urea denaturation.
The equilibrium unfolding processes of rhm-CSFO and CN157159-
modified rhm-CSFP were also monitored by fluorescence spectroscopy. As76
demonstrated in the CD experiments, the equilibrium unfolding curves for
these proteins were essentially identical, also suggesting that rhm-CSF13
and CN157'159-modified rhm-CSFI3 had similar stabilities.
3.3.2 Folding of rhm-CSFfi studied by deuterium/hydrogen (D/H) exchange
pulsed labeling.
Deuterium/hydrogen exchange pulsed labeling required the use of
an automated instrument for mixing to study the folding events on the msec
timescale.A BioLogic quenched flowinstrument was used for
mechanically performing protein folding, hydrogen labeling, and quenching
reactions.Oxidized rhm-CSFIE1 was initially unfolded in a D20-denaturant
solution in which all exchangeable amide sites were deuterated.Folding,
initiated by a rapid 11-fold dilution of the denaturant, was allowed to
proceed over variable time periods between 7.5 ms and 10 s before the
partially folded protein was exposed to a hydrogen pulse. Under this pulsed
labeling condition (pH 10, 10 ms, 8°C), the half life for D/H exchange of a
free ND is about 1 ms (Molday 1972). Therefore, the amide sites in still
unstructured parts of the protein became fully protonated while those
protected by prior formed structures remained deuterated.The labeling
pulse was terminated by adjusting the solution pH to 2.5 and the77
temperature to 0°C, conditions under which D/H exchange was slow.
The protein samples were analyzed using LC-ESI-MS. To minimize further
deuterium exchange loss from solvent hydrogen through back exchange
during HPLC analysis, the chromatography step was optimized for speed.
The frozen samples were thawed and analyzed by mass spectrometry
within 5 min. ESI-MS data showed that 227 deuteriums were maintained in
rhm-CSF13 after 7.5 ms of folding (Figure 22).
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Figure 22. Deuterium levels maintained in CN157159-modified rhm-CSFO and
rhm-CSF13 during protein folding.78
Interestingly, a loss of only 13 additional deuteriums was detected when
the folding time was extended to 10 s. This suggested that little structural
change took place during folding in the range of 7.5 ms to 10 s.
In light of these results, the folding reaction was allowed to proceed
beyond 10 s.However, because the quenched flow instrument was
incapable of mixing on the time scale of minutes or hours, a manual mixing
procedure was adapted in place of the automated mixing provided with the
quenched flow instrument.In this procedure, the pulsed labeling condition
(pH 7, 10 s, 8°C) was carefully selected so that the strength of the labeling
pulse was kept the same as in the previous experiments performed with the
quenched flow instrument.Pulsed labeling experiments with rhm-CS93
were performed at 30 different folding times between 10 s and 48 hr (Figure
22). The samples were analyzed by LC-ESI-MS. The deuterium levels in
these samples were found to be similar as those found in samples obtained
from much shorter folding times.In the range of 10 s to 48 hr, the
deuterium levels fluctuated in the range of 215 and 225, reflecting little if
any structural change. Most importantly, two samples obtained for the 10 s
folding reaction, one by automated mixing and another by manual mixing,
showed the same level of deuterium incorporation. Therefore, the pulsed
labeling conditions for both methods indeed gave the same results.79
These data indicated that rhm-CS93 folded rapidly (within 7.5 ms)
under the present folding condition (0.8 M urea at pD 8.5 at 8°C) and no
significant structural change could be detected by extending the folding
time.This finding was consistent with results obtained from previous
stopped-flow CD experimentswithrhm-CS93,which showedthat
secondary structure formation occurred rapidly (M. Schimerlik, private
communication). However, other studies using fluorescence spectroscopy
and size exclusion chromatography (C. Maier, private communication)
indicated formation of tertiary structure on the time scale of min to hr, which
was not detected in the present study.
3.3.3 FoldingofCN157'159-modified rhm-CSFfi investigated by D/H
exchange pulsed labeling.
Folding studies of CN157159-modified rhm-CS93 were carried out as
described for rhm-CS93.Both automated and manual mixing methods
were employed to investigate the folding kinetics of the oxidized protein in
the time range of 7.5 ms to 48 hr. Mass spectrometric analyses of these
samples showed that nearly 198 deuteriums were retained in the protein
within 7.5 ms after the folding reaction was initiated.The loss of 10
additional deuteriums was observed as the folding time was increased to80
10s.As the folding reaction was prolonged to 48 hr, the measured
deuterium levels fluctuated in the range of 183 to 190 (Figure 22). These
data suggested that shortly after the folding reaction was initiated CN157'159-
modified rhm-CSFP attained a significant amount of folded structure. As
the folding time was increased, the loss of a small amount of deuterium was
detected, indicating little structural change had taken place.Interestingly,
the deuterium levels in CN157'159-modified rhm-CSFp on average were
lower than the deuterium levels found in rhm -CSFI3 by about 30 deuteriums
for the same folding time.
3.3.4 Localizing deuteriums in folded proteins by proteolysis and CID MS-
MS.
In order to locate the amide sites corresponding to the deuterium
differencesinrhm-CSFP andCN157'159- modifiedrhm-CSFP,pepsin
digestion was applied to D/H exchanged proteins after various folding
times. Thirteen peptides covering more than 90% of the protein backbone
were identified in the pepsin digests of rhm-CSFp as well as in CN157'159-
modified rhm- CSFI3.81
The deuterium contentinallpeptides from rhm-CSF8 and
CN157'159-modified rhm-CSFI3 after 7.5 ms of folding were determined by
collision induced dissociation (CID) experiments (Table 5).
Table 5. Number of amide deuteriums retained in rhm-CSF8 and CN157'159-
modified rhm-CSF8 after 7.5 ms of folding.
Segment # of NHs rhm-CSFI3CN157'159-rhm-CSFp
Intact proteins 404 227 198
4-19 16 5 4
20-27 7 7 6
37-55 17 11 11
56-62 6 5 5
63-76 12 7 7
77-82 5 4 4
83-105 11 10 11
106-113 6 4 4
114-128 14 14 13
129-135 7 5 2
136-143 8 2 1
151-189 29 9 1
190-221 27 3 1
The peptides derived from both proteins exhibited an important similarity:
the peptides of the interior regions of the proteins retained far more
deuteriums than those in the N-termini and the C-termini. For instance, the
peptides covering as 4-19 showed deuterium levels of 5 (31%) and 4 (25%)82
for rhm-CS93 and its derivative while the peptides covering 83-105
showed deuterium levels of 10 (91%) and 11(100%), respectively.
However, the deuterium levels in the C-terminal regions were different
between the two proteins. This was especially pronounced in the peptides
covering aa151-189: 9 deuteriums (31°A) were retained in the peptide from
rhm-CSFI3 while only 1 deuterium (3.4%) was retained in the modified
protein.These data indicated that both proteins achieved similar overall
structures but exhibited different structural features in the C-terminal
regions after 7.5 ms of folding.
The numbers of amide deuteriums from the peptides did not equal to
those from the intact proteins because back exchange with the protonated
solvent in peptides was more complex than that for the intact proteins. For
instance, the deuteriums at the N-termini from every peptide were lost
during HPLC analysis.In some cases, depending on the sequence of the
peptide, the deuteriums from the amino acid second from the N-termini
might be lost as well (Engen, Smithgall et al. 1997).In contrast, only two
amide deuteriums at the two N-termini were lost with the intact rhm-CSFI3
and CN157'159-modified rhm-CSFI3.
In order to determine the folding kinetics, the deuterium content in
peptides derived from both proteins were analyzed over folding times
ranging from 7.5 ms to 48 hr.However, none of the peptides analyzed83
exhibited any change in deuterium levels as the folding time increased.
For instance, peptides covering aa 83-105 from both proteins showed
unchanged deuterium levels of 10 and 11 (Figure 23). In peptides covering
aa 151-189, the deuterium levels remained the same at 9 and 1 (Figure 23)
for rhm-CSFI3 and CN157'159-modified rhm-CS93, respectively.Thus, rate
constants for specific kinetic processes could not be determined.It is
intriguing that the intact proteins exhibited slight deuterium loss whilenone
of the peptides showed any decrease in deuterium levels.It is possible that
most of the amide deuteriums loss occurred in sites that were closer to the
N- and C-termini of the peptides.
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Figure 23. Deuterium levels in peptides covering aa 83-105 (A) and
peptides covering aa 151-189(B) remained unchanged during the
folding of rhm-CSF13 and CN157'159-modified rhm-CSF13.84
3.4Conclusion
Deuterium/hydrogen exchange pulsed labeling was used to study the
folding kinetics of rhm-CS93 and CN157159-modified rhm-CS93.Both
proteins exhibited fairly high levels of deuterium, which were sustained
throughout folding.The fact that little additional deuterium loss was
detected in the two proteins suggested that the proteins attained three-
dimensional structural features characteristic of the folded proteins.In the
presence of all nine disulfide bonds, unfolded rhm-CSFO quickly folded into
the native conformation.In the case of CN157159-modified rhm-CSFO, the
data suggest that the disulfide bonds linking Cys157/159-Cys'157/159 did
not greatly affect protein folding kinetics.It may be that D/H exchange
pulsed labeling was not able to detect the change in folding kinetics
resulting from the absence of Cys157/159-Cys'157/159.
A comparison of the data from the native state deuterium exchange
experiment (Zhang, unpublished result) and the deuterium exchange pulsed
labeling experiment provided interestingresults.In the native state
deuterium exchange experiment, fully deuterated proteins were subjected
to exchange with protic solvent for 10 s. The deuterium levels determined
in these samples were nearly identical as those from the pulsed labeling
experiment in which the proteins were subjected to a 10 s hydrogen pulse.85
These results indicated that the folded proteins prior to the proton pulse
in the pulsed labeling experiment shared similar structural features with the
folded proteins prior to the 10 s D/H exchange.It has been suggested that
residues with slowly exchanging amide deuteriums fold early on the kinetic
folding pathways (Woodward 1993).In the case of rhm-CS93 and
CN157'159-modified rhm-CS93 folding, there were many slow exchanging
amide deuteriums which must have been shielded from exchange during
early folding.
3.5Material and methods
3.5.1Materials.
Purified rhm-CS93 was provided by Dr. C. Cogwill (Chiron Corp.
Emeryville, CA).Tris(2-carboxyethyl)phosphine (TCEP) and immobilized
pepsinwereobtainedfromPierce(Rockford,IL). 1 -cyano-4-
dimethylaminopyridinium fluoroborate (CDAP) was obtained from Sigma
Chemicals. Modified trypsin was purchased from Promega (Madison, WI).
Deuterium oxide and urea-d4 were obtained from Aldrich Chemical Co.86
(Milwaukee, WI).All other chemicals and reagents were of the highest
grade commercially available.
3.5.2 Preparation of CN 15' 159-modified rhm-CSFfi.
The freshly dissolved rhm-CSFI3 (12nmol) was solubilized in 300 ill
of 20 mM ammonium acetate buffer (pH 3.5) containing 1 mM EDTA.
Partial reduction of rhm-CSFO was initiated by adding 0.05 equivalent of
TCEP of total cysteine content and followed by incubation at room
temperature for 5 hrs.After TCEP was removed by centrifugal filtration
using ultrafree MC filters with a 5,000 Da molecular mass cutoff (Millipore),
a 25-fold molar excess of CDAP solution relative to the cysteine content
was added to the partially reduced protein mixture.Cyanylation of the
sulfhydryl groups was carried out at room temperature for 10 min. CDAP
was then removed by centrifugal filtration. The reduced, cyanylated protein
was purified by reverse phase high performance liquid chromatography
(HPLC) on a Vydac C4 TP214 column (300A, 5 gm, 4.6X250 mm, 1 ml/min
flow rate) employing a binary linear gradient elution with 0.1% trifluroacetic
acid(TFA) as solvent A and acetonitrile(ACN) containing 0.09%87
trifluroacetic acid as solvent B. The proteins were eluted usinga 60 min
44-54% B gradient.Protein fractions were collected manually and
lyophilized.
3.5.3 Equilibrium unfolding studied by circular dichroism and fluorescence.
rhm-CSFO anditsderivativeweredissolvedtoaprotein
concentration of 0.3ug/ul in 50 mM Tris buffer solution (pH 8.5) containing
concentrations of urea ranging from 1 M to 9 M.The solutions were
equilibrated overnight at room temperature. All measurementswere carried
outat25°C.CD spectra were obtainedusing a Jasco J720
spectropolarimeter (Jasco Inc., Easton, MD) over therange of 185-310 nm
in a cylindrical 1-cm path length quartz cuvette witha bandwidth of 2nm and
a scan speed of 10nm/min. Fluorescence data were acquired on an SLM
8100C fluorescencespectrometer (SLMInstrumentsInc.,Urbana-
Champaign, IL) with 8 nm emission and excitation slit widths usinga square
0.5 cm path length quartz cuvette. The intrinsic tryptophan residueswere
excited at 280 nm, and emission spectrawere recorded at a wavelength
range of 300 to 420 nm and expressed as a ratio of emission intensity to
reference emission intensity.88
3.5.4 Folding studied by quenched-flow deuterium hydrogen exchange
pulsed-labeling.
Deuterium hydrogen exchange pulsed labeling experiments were
performed on a QFM-4 quenched flow module (BioLogic,Echirolles,
France) at 8°C. rhm -CSFI3 and its derivative (80 uM) were unfolded in a
deuterated buffer containing 50 mM Tris, 8.5 M urea -d4 at pD 8.5. Under
these conditions,all backbone amide protons exchange rapidly with
deuterons from the solvent. Folding was initiated by an 11X dilution of the
denatured proteins with the folding buffer containing 50 mM Tris at pD 8.5.
The resulting denaturant concentration (0.77 M urea -d4, pD 8.5, 10°C) was
well below the equilibrium unfolding transition for rhm-CSFp and CN157'159-
modified rhm-CSFp. The folding times ranged from 7.5 ms to 10 s. The
labeling reaction was initiated by rapidly mixing the partially folded protein
solution with an equal volume of 25 mM Tris buffer in H2O at pH 11,
resulting in a jump to pH 10. The 10 ms pulse was terminated by lowering
the pH to 2.5 in a final mixing step with the quenching buffer (0.5 M HCI).
The samples were concentrated using a Millipore microconcentrator and
stored at -80°C prior to mass spectrometric analysis.89
3.5.5 Folding studied by manual mixing deuterium hydrogen exchange
pulsed-labeling.
rhm-CSFO (80 uM) and its derivative were unfolded in a deuterated
buffer containing 50 mM Tris, 8.5 M urea-d4 at pD 8.5. Folding was initiated
by an 11X dilution of the denatured proteins with the folding buffer
containing 50 mM Tris at pD 8.5 and 8°C. The folding times ranged from 10
s to 48 hr. The labeling reaction was initiated by rapidly mixing the partially
folded protein solution with an equal volume of 25 mM Tris buffer in H2O at
pH 6, resulting in a jump to pH 7.The 10 s pulse was terminated by
lowering the pH to 2.5 in a final mixing step with the quenching buffer (0.5
MHCI). ThesampleswereconcentratedusingaMillipore
microconcentrator and stored at -80°C prior to mass spectrometric analysis.
The deuterated refolded protein samples were analyzed by LC-ESI-triple
quadrupole MS (PE-Sciex API 1111 using a self-packed C4 column (5 j.tm
particle size, 300 A pore size, 20 µL/min flow rate) and a binary gradient
elution involving 0.05% TFA as solvent A and ACN containing 0.05%TFA
as solvent B.After desalting at 10%B for 2min, the protein was eluted
using a 3 min 10-80% B program. The HPLC injector and the column were
submerged in ice/water slurry, and the transfer syringe pre-cooled on ice
before use. MS spectra were analyzed by BioSpec software.90
3.5.6 Determination of the localized deuterium content in folded proteins
by pepsin digestion and CID-MS-MS.
The samples obtained from various folding times were digested with
pepsin (protein/enzyme = 1/2) in 0.1 M ammonium phosphate buffer (pH 2.5,
0°C, 1:1 D20/H20) containing 8 M urea-d4 and 1 M TCEP at 0°C for 5min.
This procedure yielded 90% coverage of the entire backbone. The digest
mixture was analyzed using the LCQ-ESI-ion trap mass spectrometer.A
C18 Luna HPLC column (5 gm particle size, 100 A pore size, 15 111./min
flow rate) and 0.05%TFA as solvent A and ACN containing 0.05% TFA as
solvent B was used for separation. After desalting for 2min, peptides were
eluted with the following program: 10-20%B for 1min, 20-30%B for 1min,
30-45%B for 2min, 45-60%B for 1min, 60-90%B for 3min. To minimize
deuterium back exchange, the injector and column were immersed in an
ice/water bath, and the transfer syringe was rinsed with D20 and cooled on
ice before use. MS spectra were analyzed using Sequest software.91
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4 Structural Elucidation of Intermediates in rhm-CSFO Folding by
Disulfide Bond Quenching and H/D pulsed labeling
4.1Abstract
In vitro folding of recombinant human macrophage colony stimulating
factor beta (rhm-CS93) involves the systematic formation of disulfide bonds
via multiple pathways.Evidence was obtained by mass spectrometry for
the formation of native as well as non-native intramolecular disulfide bonds
in the monomeric folding intermediates.Initial dimerization involved the
formation of disulfide bonds Cys157/159-Cys'157/159. Among three intra-
subunit disulfide bonds Cys48-Cys139 and Cys'48-Cys'139 were the last to
form, while Cys31-Cys'31 formed the last inter-subunit disulfide bond. An
hydrogen/deuterium (H/D) exchange pulsed labeling experiment showed
the coexistence of dimeric and monomeric species of non-compact
conformation at early stages of folding.As folding proceeded, the
deuterium level dropped rapidly in the dimer, losing 20% deuterium label
within 50 min, suggesting that the non-compact dimer underwent significant
structural rearrangement,The deuterium level remained high in the
monomer throughout extended folding,indicatingthat the monomer
maintained a non-compact conformation.93
Key Words: oxidative folding, disulfide bond quenching, H/D pulsed
labeling, rhm-CSFI3,
4.2Introduction
Protein folding is an important process for understanding structure-
functionrelationship.A thorough understanding of the fundamental
principles of protein folding may lead to the high level production of
biologicallyactiveproteins of therapeutic and diagnostic importance
(Dobson 1998; Liu 1998). A general solution to the protein folding problem
requires the delineation of folding pathways, which can be constructed by
identifying the structural and energetic characteristics of the folding
intermediates and placing them in some kind of logical order.Extensive
research efforts have been devoted to elucidating the thermodynamics and
kinetics of the intermediates along the folding pathways (Lu 1992; Onda
1997; Chang 2001; Zhou 2001).
The protein folding process is highly complex; it involves various
chemical interactions of individual amino acids, such as disulfide bonding
and hydrogen bonding.By experimentally manipulating these chemical
interactions,itis possible to trap intermediate conformations that occur94
during protein folding.In proteins containing disulfide bonds, for
example, the folding process can be studied by examining the extent of
disulfide bond formation at various stages of folding by disulfide bond
quenching, i.e. trapping of the intermediates with nascent sulfhydryl groups
(Creighton 1978). Detailed folding pathways have been defined for several
proteins by analyzing the pattern of modified and non-modified cysteine
residues in the folding intermediates (Weissman 1991; Lu 1992; Glocker,
Arbogast et al. 1994).
Folding pathways can also be elucidated by monitoring the formation
of hydrogen bonding that occurs in protein folding.It is difficult,if not
impossible, to manipulate and detect the formation and breakage of all
hydrogen bonds throughout protein folding. However, it is possible to trap
the intermediates by deuterium labeling using amide hydrogens (NHs) as
reporter groups. Amide H/D exchange pulsed labeling utilizes deuterium
exchange to label NHs on the polypeptide backbone that are unprotected at
defined folding times (Clarke 1997). The levels of deuterium trapped at
different folding times can be determined by nuclear magnetic resonance
(NMR) and/or electrosprayionization mass spectrometry(ESI-MS).
Transient folding intermediates that are undetected by other conventional
spectroscopic methods have been identified by H/D pulsed labeling (Roder
1988; Bai, Sosnick et al. 1995; Tsui, Garcia et al. 1999).95
rhm-CSF6 was expressed from Escherichia coli as a truncated
form (aa 4-218, 49KDa) of one of the three human cDNA clones (Pandit
1992).It is a glycoprotein that stimulates the proliferation, differentiation
and survival of cells belonging to the monocyte-macrophage lineage both in
vivo and in vitro (Stanley 1994). The effects of rhm-CSF6 are mediated
throughbindingtoitsreceptor,M-CSFR,whichisanintegral
transmembrane glycoprotein that functions as a ligand-activated protein
tyrosine kinase (Bourette 2000).Mature rhm-CSF6 is a homodimer with
threeinter-subunitdisulfidebonds(Cys31-Cys'31,Cys157/159-
Cys'157/159) and three intramolecular disulfide bonds (Cys48-139, 7-90,
102-146) (Figure 4).The assembly of the monomeric subunits and the
maturation of the biologicalactivity were shown to depend on the
progressive formation of the correct disulfide bonds during in vitro folding
(Glocker, Arbogast et al. 1994). Consequently, it is important to study the
structures of disulfide intermediates and their order of formation in folding.
However, the number of possible disulfide bonded intermediates increases
rapidly with increasing numbers of cysteine residues available for disulfide
bond formation.For a protein with nine disulfide bonds and eighteen
cysteine residues, such as rhm-CSF6, the number of possible disulfide
bonded species is enormous, exceeding 30,000,000 (Jaenicke 1989).
Therefore,itis a daunting task to attempt isolation and analysis of all96
disulfide scrambled isomers occurring in the folding pathways of rhm-
CSF(3.However, isolating and characterizing the few major disulfide-
bonded intermediates and placing them in a time-dependent order may help
to elucidate some folding events for rhm-CSFI3.In the present study, the
folding of rhm-CSFI3 was investigated by disulfide bond quenching and H/D
pulsed labeling.
4.3Results
4.3.1In vitro folding monitored by disulfide bond quenching.
In order to study the intermediates involved in rhm-CS93 folding, a
purified sample of native rhm-CSF6 was denatured and reduced.The
complete conversion from dimer to monomer was verified by size exclusion
chromatography and mass spectrometry (data not shown). Folding was
initiated by rapid buffer exchange of the denatured, reduced protein solution
into the folding buffer containing GSSG/GSH. Carboxyamidomethylation
was used to trap the intermediates in the time course folding experiment.97
Mixtures of trapped intermediates were analyzed by mass spectrometry
without HPLC fractionation.
The mass spectra recorded of the intermediates for folding times
ranging from 1 min to 7,200 min showed that the charge state distributions
shifted from one centered on peaks with low m/z values toone centered on
peaks with high m/z values (Figure 24). A charge state distribution
centered on peaks with low m/z values represented monomeric proteins
whose molecular weights (MWs) were half that for dimeric proteins (Figure
24. 1min). A distribution centered on high m/z valueswas indicative of
compact dimeric proteins (Figure 24. 7,200 min).During this transition,
there were charge state distributions centered on medium m/z values
(Figure 24. 120 min). These distributions corresponded to dimeric species
that had non-compact structures in which many basic siteswere available
for protonation during electrospray ionization.The shift in charge state
distributions represented a conversion from non-compactmonomers to
non-compact dimers and eventually to compact dimers. The overlapping
charge statedistributionsindicated monomeric and dimeric species
coexisted at different stages of folding.
Each mass spectrum represented a time-dependent mixture of
folding intermediates. For instance, the mass spectrum after 1 min folding
indicated the presence of two protein forms (Figure 25. A). Deconvolutiona)
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Figure 24. Carboxyamidomethylated intermediates of rhm -CSFI3 after
folding for different incubation periods in GSH/GSSG (7.8/1).
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99100
of the mass spectrum provided the MWs for these two proteins: 25,034
Da and 24,929 Da, corresponding to monomeric proteins with 9 and 7
alkylated cysteine residues, respectively (Figure 25. B).After 300 min
folding, the folding mixture became more complex, exhibiting multiple
overlapping charge state distributions (Figure 25. C).Deconvolution
identified these species to be monomeric and dimeric proteins of various
degrees of carboxyamidomethylation. The oxidative folding of rhm-CSFO
approached completion after 7,200 min.The mass spectrum showed a
distribution of charge states centered on 21+, the same as in the mass
spectrum of the native protein, indicating that nearly all species were
converted to the native protein by this time. When the charge states were
deconvoluted, the presence of a small population of a monomer containing
4 disulfide bonds and 1 alkylated cysteine residue became apparent even
though the charge state distribution characteristic of a monomer was not
detected.
The samples collected after various folding times consisted of
complexmixturesofmonomeric anddimericspeciesthatwere
differentiated by their MWs. The identities of each species in the folding
mixture were assigned based on their MWs obtained by deconvoluting the
mass spectra and comparing them with calculated values (Table 6).It is
important to note that quantitative or qualitative comparisons between the101
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Figure25.(A)Chargestatedistributionscorrespondingto
carboxyamidomethylated monomers. (B) Molecular weights obtained by
deconvolution. (C) Heterogeneous monomeric and dimeric proteins of
various degrees of carboxyamidomethylation.Table 6. Disulfide bonds in rhm-CSFI3 folding intermediates.*
Time (min)M-SSO-cam9M-SS1-cam7M-SS2-cam5M-SS3-cam3M- SS4 -camlD-SS6-cam6D-SS7-cam4D-SS8-cam2D-SS9-cam0
1 1 2
11 1 2 3
15 1 2 3 4
20 2 1 3 4
25 2 1 3 4
45 3 2 1 4 1
75 1 2 3 2 1
103 2 1 3 3 1 2
120 3 1 2 3 1 2 4
180 3 1 2 4 1 2 3
305 3 2 1 4 2 1 3
480 2 1 4 2 1 3
970 2 1 2 1 3
1,200 2 1 3 1 2
1,279 2 1 2 1 3
1,513 2 1 3 2 1
2,565 1 3 2 1
4,800 1 2 1
7,200 1 1
MW' (Da)25,045 24,929 24,810 24,697 24,578 49,268 49,377 49,144 49,036
MW2 (Da)25,037 24,921 24,805 24,689 24,573 49,262 49,378 49,146 49,030
* cam refers to carboxyamidomethylation, SS refers to disulfide bond. MW' is themeasured molecular weight
and MW2 is the calculated molecular weight. Numberswere assigned based on the abundance of the protein
form in the mass spectra: 1 being the most populous and 4 being the least abundant.
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monomeric and dimeric proteins cannot be made simply based on their
relative peak intensities in the mass spectra. This is because monomeric
and dimeric proteins exhibit different molar sensitivitiesin the mass
spectrometer,perhaps becauseofdifferentelectrosprayionization.
Monomeric proteins are less structured and are ionized more efficiently
than the compact dimeric proteins.However, amongst monomeric or
dimeric proteins,itis possible to make qualitative comparisons of the
abundance of these species based on their relative peak intensities in the
mass spectra. Numbers were assigned to each folding intermediate based
on their relative intensities in the mass spectra, 1 being the most populous
and 4 being the least abundant (Table 6).
Overall monomeric proteins were converted to dimeric species and
eventually to the native rhm-CS93 (Table 6).The folding process was
characterized by an increasing number of disulfide bonds anda decreasing
number of alkylated cysteine residues in both monomeric and dimeric
foldingintermediates. At early foldingtimes, the monomer with 9
carboxyamidomethylated cysteinyl residues, M-SSO-cam9, was the most
abundant.As folding proceeded, other monomers with fewer alkylated
cysteinyl residues became more abundant, indicating thatmore disulfide
bonds had formed. A dimer containing 4 carboxyamidomethylated cysteinyl
residues, D-SS7-cam4, was detected in the 45 min folding mixture which104
marked the beginning of the transition from monomeric to dimeric
proteins. Subsequently, other dimeric proteins appeared exhibiting a lesser
degree of carboxyamidomethylation and a higher degree of disulfide bond
formation.Folding of rhm-CSFI3 approached completion after 7,200 min
when the folding sample contained mainly D-SS9-cam0, a dimeric protein
with 9 disulfide bonds.In the same sample, a monomer containing 4
disulfide bonds and 1 carboxyamidomethylated cysteinyl residue, M-SS4-
caml, was also detected, representing species trapped in non-native
disulfide bonded conformations and was, therefore,less capable of
productive folding.
4.3.2 Isolation of folding intermediates.
To further characterize the folding intermediates, the folding reaction
was performed on a larger amount of denatured and reduced rhm-CSF13
(0.5 mg, 10 nmol) for 1, 120, and 4,800 min. The folding intermediates
were separated on an analytical Vydac C4 column by RP-HPLC.All
fractions were collected, lyophilized and subjected tomass spectrometric
analysis. Under the present HPLC conditions, the native dimer (D) hada
retention time of 12.5 min and the fully alkylated monomeric protein (M) had105
a retention time of 13.4 min. As expected, reduced and denatured rhm-
CS93 monomer migrated with the longest retention time due toits
hydrophobic nature. The measured molecular weights for the native dimer
and the fully alkylated monomer were 49,036 Da and 25,034 Da,
respectively.
The HPLC trace for the folding mixture obtained after 1 min showed
a single peak at 13.4 min (Figure 26). Mass spectrometric analysis of the
isolated protein indicated that the protein had an average MW 25,038 Da
and was a fully alkylated monomer M-SSO-cam9 (Table 7). The presence
of a monomeric protein containing 7 alkylated cysteine residues, M-SS1-
cam7, was detected in the oxidative folding sample that was not HPLC
fractionated. However, this protein was not detected in any HPLC fraction,
perhaps due to its low abundance in the folding mixture. HPLC analysis of
the folding mixture quenched after 120 min folding provided four fractions of
intermediates, identified with retention times of 12.4, 12.8, 13.1, and 13.4
min (Figure 26).All fractions were analyzed by mass spectrometry (Table
7). The 12.4-min fraction represented a single protein withan average MW
49,030 Da, the same as D-SS9-cam0.The 12.8-min fraction contained
two species with MWs 49,144 Da and 49,377 Da, corresponding to dimeric
proteins with 2 and 6 carboxyamidomethylated cysteinyl residues, namely
D-SS8-cam2 and D-SS6-cam6. The 13.1-min fraction contained two1.0 -
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Figure 26.Disulfide bond quenched folding intermediates separated by
RP-HPLC.Table 7. Mass spectrometric analysis of HPLC fractionated folding mixtures. *
Time (min)HPLC poolsMW (Da) Identification Cys-cam Free Cys Cys-SG
1 13.4 min 25,038 M-SSO-cam9 7, 31, 48, 90, 102, none none
139, 146, 157, 159
120 12.5 min 49,030 D-SS9-cam0 none 7, 31, 48, 90, 102 none
139, 146, 157, 159
12.8 min 49,144 D-SS8-cam2 31, 48, 139 7, 48, 90, 102, 139, none
49,377 D-SS6-cam6 146, 157, 159
13.1 min 25,054M-SS2-cam4/GS131, 48, 146, 157, 159 7, 90, 102, 139 31
24,805 M-SS2-cam5
13.4 min 24,692 M-SS3-cam3 31, 157, 159 7, 48, 90, 102, 139, 146 none
4800 12.4 min 49,031 D-SS9-cam0 none 31, 48, 90, 139,146, 157,none
159
12.9min 49,14e D-SS8-cam2 31 48, 90, 139, 146, 157, none
159
RF refers to refolding time, cam refers to carboxyamidomethylation and MW refers to molecular weight.108
monomeric species.One with MW 24,805 Da corresponding to a
monomer with 5 carboxyamido-methylated cysteinyl residues M-SS2-cam5.
The other had MW 25,045 Da representinga monomer with 1
glutathionylated and 4 carboxyamido-methylated cysteinyl residues M-SS2-
cam4-SG1.The 13.4-min fraction contained a single protein with MW
24,692Dathatwasconsistentwithamonomerwith3
carboxyamidomethylated cysteinyl residues M-SS3-cam3.The 12.8-min
and the 13.1-min HPLC pools contained protein mixtures and were
subjected to further separation by reversed phase and ion exchange
chromatography.However, no improved separation was achieved,
probably due to the similarities of the hydrodynamic and ionic properties of
the co-eluting proteins.
The mixture collected after 4,800 min folding was separated by RP-
HPLC, producing a major peak with a retention time of 12.4-min and a
minor peak with a retention time of 12.9-min. The mass spectra of these
two fractions provided the MWs: 49,031 Da corresponding to the native
rhm- CSFI3,49,146 Da consistentwithadimericproteinwith2
carboxyamidomethylated cysteinyl residues D-SS8-cam2. The monomeric
protein with 4 disulfide bonds and 1 carboxyamidomethylated cysteinyl
residue, M-SS4-cam1, was not identified in any HPLC fraction even though
this protein was detected in the non-separated mixture.109
4.3.3 Identification of folding intermediates by peptide mapping.
To further characterize thestructuresofthe variousfolding
intermediates isolated after 1, 120 and 4,800 min folding, these proteins
were analyzed by peptide mapping using pepsin proteolysis and collision
induced dissociation tandem mass spectrometry (CID MS-MS).Each
HPLC fractionated pool was subjected to reduction to remove existing
disulfidebondsinorder toachieve complete enzymaticdigestion.
Consequently, those cysteine residues that did not participate in disulfide
bridgesatthetimeofdisulfidebondquenchingwere
carboxyamidomethylated and those residues that were members of
disulfide bonds were free of alkylation.
In the HPLC fraction collected after 1 min folding, a single protein, M-
SSO-cam9, was detected. A CID MS-MS experiment of the pepsin-digested
sample verified that all 9 cysteine residues were carboxyamidomethylated
in this monomer (Table 7), indicating that no disulfide bond had formed after
1 min folding.
Four HPLC fractions were obtained after 120 min folding.Mass
spectrometric studies of these fractions indicated that two of the fractions
contained mixtures of proteins that could not be further separated from
each other.Therefore, the peptic digests of each HPLC pool contained110
peptides derived from co-eluted proteins (Table 7).In the 12.5-min
fraction, a single dimeric protein, D-SS9-cam0, was isolated andit
contained no modified cysteinyl residues, indicating thatallcysteinyl
residues were involved in disulfide bonding.In the 12.8-min fraction that
consisted of dimeric proteins D-SS8-cam2 and D-SS6-cam6, peptide
mapping showed that several cysteine residues were
carboxyamidomethylated, including Cys 31, 48 and 139.In addition,
cysteine residues 7, 48, 90, 102, 139, 146, 157 and 159 were found to be
free of alkylation. These non-modified residues were among the disulfide
bonds that had formed after 120 min folding in proteins that eluted at 12.8
min. In these proteins, the intermolecular disulfide bond linking Cys 31 and
Cys' 31 had not yet formed. Interestingly, Cys 48 and Cys 139 were found
in both the modified and non-modified forms, indicating that some protein
molecules contained an open Cys48-Cys139 disulfide bridge while others
had the intact Cys48-Cys139 disulfide bond.
Inthe13.1-min fractioncollectedafter 120 min folding, two
monomeric proteins, M-SS2-cam4-SG1 and M-SS2-cam5, were identified
by ESI-MS analysis (Table 7).CID MS-MS experiments of this fraction
showed a highly complex mixture of alkylated and non-modified cysteinyl
residues. Carboxyamidomethylated cysteinyl residues included Cys 31, 48,
146, 157 and 159. The same CID MS-MS experiment also indicated that111
Cys 7, 90, 102 and 139 were free of alkylation. Cysteine 31 was also
found to be glutathionylated. Because M-SS2-cam4-SG1 and M-SS2-cam5
were eluted with the same HPLC retention time and they both contained 5
modified cysteine residues (Cys31, 48, 146, 157 and 159), it is likely that
they might contain similar disulfide structure in which case Cys 31 was
carboxyamidomethylated in M-SS2-cam5 and Cys 31 was glutathionylated
inM-SS2-cam4-SG1.Residues Cys48,146,157 and 159 were
carboxyamidomethylated in both monomers. These data verified that in
these monomeric proteins, Cys 31,157 and 159, which form the
intermolecular disulfide bonds in native rhm-CSFI3, were not involved in any
disulfide bridges. Importantly, some cysteine residues that were involved in
disulfide bonds at the time of disulfide bond quenching did not have the
same disulfide partners as in the native protein.For instance, in native
rhm-CSF13, Cys 102 forms a disulfide bridge with Cys 146, and Cys 139
bonds with Cys 48.However, Cys 48 and Cys 146 were modified with
carboxyamidomethylation while Cys 139 and Cys 102 were free of
alkylation.These data signified that the disulfide bonds formed in the
monomeric proteins after 120 min were not the native disulfides as formed
in rhm-CSF93. The presence of non-native disulfide bonds suggested that
thefoldingofrhm-CS93involveddisulfidebondshuffling,which
represented an important isomerization process catalyzed by GSH/GSSG.112
The 13.4-min fraction was shown to contain a single monomeric protein,
M-SS3-cam3, in which three cysteine residues were
carboxyamidomethylated, including Cys 31, 157 and 159.
After folding had proceeded for 4,800 min, two HPLC pools were
collected. One fraction contained D-SS9-cam0 and the other contained D-
SS8-cam2. Analysis of the peptic peptides of the first fraction indicated that
all 9 cysteine residues were free of alkylation, which confirmed their
involvement in disulfide bonds.The pepsin digests of the later fraction
showed thatall cysteine residues, other than Cys 31, were free of
alkylation. Thus, D-SS8-cam2 contained two intermolecular disulfide bonds
linking Cys 157/159 and Cys' 157/159. Interestingly, this protein had similar
molecular weight and HPLC retention time as a protein found in the 12.8
min fraction after 120 min folding.These are likely the same protein
intermediate present in the folding mixture over an extended time.In this
case, D-SS8-cam2 in the 12.8-min fraction after 120 min folding must
contain unmodified Cys31 and Cys'31.Therefore, D-SS6-cam6 isolated
from the same HPLC pool must contain unmodified Cys31, Cys157,
Cys159 and Cys'31, Cys'157 and Cys'159 (Table 7).113
4.3.4In vitro folding monitored by deuterium exchange pulsed labeling.
The progress of rhm-CS93 folding was also monitored by deuterium
exchange pulsed labeling.Denaturation, reduction, and folding of rhm-
CS93 were performed in protonated solvents as in the disulfide bond
quenching experiment. After each folding time, an aliquot of sample was
removed and subjected to 10-fold dilution into deuterated solvent for 10 s.
During the labeling time, all accessible amide hydrogens (NHs) became
deuterated, while those that remained protonated were assumed to be
either involved in hydrogen bonding or buried deep within the folded
protein. The labeling pulse was quenched by lowering the solution pH to
2.5 and the temperature to 0°C.In this experiment, disulfide bond
quenching was not performed because disulfide bond formation was
assumed to slow significantlyunder the H/D exchange quenching
conditions (acid pH and low temperature).The protein samples were
analyzed directly by ESI-MS.
After 1 min folding, a monomer was present and nearly 80% of all
exchangeable NHs had exchanged to deuteriums, indicating that the
protein had a non-compact overall conformation (Figure 27). After 40 min,
a dimer appeared along with the monomer. The dimer also exhibited a high
level of deuterium, incorporated by -80% of the available amide sites. The114
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Figure 27. Time-dependence of deuterium levels in refolded rhm-CS93
after H/D pulsed labeling.115
high levels of deuterium incorporation indicated there was easy access
of the deuterated solvent to NHs in the dimer; therefore the dimer must also
have a non-compact overall conformation. The monomer continued to be
present in the folding mixture and the level of deuterium incorporation
remained high at -80%. The deuterium level in the non-compact dimer
decreased steadily from 80% to 75% between 40 min and 400 min folding.
After 400 min, deuterium incorporation in the dimer rapidly decreased from
75% to -50% of all amides within 50 min. The deuterium level in the
compact dimer remained at -50% throughout the remainder of the folding
time course.Deuterium incorporation for the native rhm -CSFI3 was 46%.
These results indicate that the native dimer structure wasmore compact
and less susceptible to H/D exchange than the compact dimer present in
later stages of folding.
4.4Conclusion
HPLC analysis indicated that the transition from the denatured and
reduced polypeptides tothe compactly folded rhm-CS93 was 87%
complete within 7,200 min (120 hr) under the present folding condition.
Complex mixtures of folding intermediates were present throughout the116
course of folding.The time-dependent folding events revealed that
rhm-CSFI3 molecules passed throughboth monomeric and dimeric
intermediate states, suggesting that the denatured and disulfide bond
reduced rhm-CSFO folded via multiple pathways (Figure 28). Intermediates
isolated after 1, 120, and 4,800 min folding were subjected to detailed
structural analysis by HPLC fractionation and peptide analysis. Monomeric
intermediates were predominant during early folding.Several cysteine
residues were shown to participateinnon-native disulfide bonds in
monomericintermediates,suggestingthatdisulfidebondshuffling
represented an important step during early folding.Initial dimerization was
achievedbyformingintermoleculardisulfidebondsCys157/159-
Cysl 57/159.The presence of D-SS8-cam2 in both 120 and 4,800 min
folding mixture indicated thatitmight be a thermodynamically stable
intermediate whose conversion to the native protein was slow.The
conversion of D-SS8-cam2 to the native state only required the formation
the last intermolecular disulfide bond Cys31-Cys'31.This process was
relatively slow perhaps because D-SS8-cam2 required major structural
rearrangement to facilitate the formation of Cys31-Cys'31.
H/D pulsed labeling data indicated the coexistence of dimeric and
monomeric species of non-compact conformations, which is in agreement
with multiple pathways for rhm-CSFP folding. The deuterium level in theH
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non-compact dimer decreased steadily from 80% to 75% between 40
min and 400 min (Figure 27), indicating minor conformational changes
associated with protein folding.After 400 min, the non-compact dimer
started to collapse to a more compact form, losing 20% deuterium label
within 50 min.The rapid reduction of the deuterium level in the non-
compact dimer suggested that the protein underwent a rapid structural
contraction, which significantly limited the accessibility of NHs to solvent
deuterium.Clearly, the transformation of the non-compact to the compact
dimer involved slow conformational changes followed by a fast structural
change. The deuterium level remained at 80% for the monomer throughout
the foldingtie course suggesting that deuterium accessibilityinthe
monomer was not affected even after intramolecular disulfide bonds had
formed.
Folding of rhm-CSFf3 monitored by disulfide bond quenching and
H/D pulsed labeling was conducted under the same conditions, including
the same protein concentration, oxidant concentration, i.e. GSH/GSSG
ratio, reaction temperature, pH, and folding times.Therefore, these two
experiments should provide results regarding the same intermediates on
the folding pathways.As demonstrated in the disulfide bond quenching
experiment, rhm-CSFP folding was characterized by complex mixtures of
monomeric and dimeric intermediates.Consequently, the monomer, the119
non-compact dimer and the compact dimer detected in the H/D pulsed
labeling experiment must represent ensembles, which contain proteins with
similar degrees of deuterium accessibility. The contents of the ensembles
can be approximated by correlating the data obtained from disulfide bond
quenching and H/D pulsed labeling studies.The monomer ensemble
contained all monomeric species.The non-compact dimer ensemble
included D-SS6-cam6 and D-SS7-cam4. The compact dimer ensemble
consisted of D-SS8-cam2 and D-SS9-cam0. Therefore, the transition from
the non-compact to the compact dimer involved an ensemble switch from
species with fewer disulfide bonds to those with a high degree of disulfide
bonds. The compact dimer obtained after 7,200 min folding exhibited 5%
higher deuterium incorporation than the native rhm-CS93. This difference
indicatesthat D-SS9-cam0 didnotfullyattainthe same compact
conformation as the native protein even though all native disulfide bonds
had formed.
A previous folding study performed with rhm-CSF8 was performed
under reducing conditions (0.4 mM residual DTT SH plus 0.4 mM GSH plus
0.5 mM protein SH / 0.4 mM GS" = 3.3) and provided evidence for the
following model (Glocker, Arbogast et al. 1994):
2M -> 2M' 4- D' -' D Equation 9120
At early folding times, monomers (M) formed intermediates (M') that
involved no disulfide bonds.After 17 hr folding, Cys 157/159 and Cys'
157/159 formed thefirstdisulfidebonds and facilitatedtheinitial
dimerization, resulting in the formation of a dimeric intermediate (D').
Further oxidation converted D' to the fully biologically dimer (D) after 72 hr
folding.
The present study examined the intermediates on the folding
pathways of rhm-CSF13 under slightly stronger reducing conditions (0.5 mM
GSH plus 0.11 11M protein SH / 0.64 mM GS" = 7.8).Even though the
present condition was more reducing than Glocker's study, oxidation of
disulfide bonds proceeded more quickly than reported by Glocker: the first
dimeric proteins were observed after 45 min compared to 17 hr.This
discrepancy may be due to the superior detection sensitivity provided by
electrospray ionization mass spectrometry (ESI-MS) used in the present
study in contrast to fast atom bombardment mass spectrometry (FAB-MS)
used by Glocker.In other words, dimeric proteins might be present during
early folding in Glocker's study but were not detected due to the low
detection sensitivity of FAB-MS.Another difference between the two
folding studies is that the monomeric intermediates isolated in the present
study contained disulfide bonds which Glocker failed to observe.This
difference is puzzling because a much higher molar ratio of iodoacetamide121
to free cysteine residues (20:1) was employed in the present study than
in Glocker's study (1:1).Consequently, the presence of disulfide bonds
detected in the monomeric intermediates in the present study, whichwas
deduced from the lesser degree of carboxyamidomethylation,was not
caused by underalkylation. Finally, the data presented in the present study
indicated that the denatured and disulfide bond reduced rhm-CSFO folded
via multiple pathways involving both monomeric and dimeric intermediates.
Consequently, rhm-CSF8 folding is not a simple sequential formation of
native disulfide bonds as proposed by Glocker. Instead, rhm-CSF13 folding
is a diffusion-like process as described by the "folding funnel", which
involves bumpy energy landscapes with kinetics traps and energy barriers
where the protein folds to the native state via multiple pathways in the
conformational space (Dill 1997; Dobson 1998).
m-CSFa (aa4-149) is a shorter form of m-CSFO and contains all
disulfide bonds found in mCSFI3 except Cys157/159-Cys'157/159. A study
of folding intermediates involved in the folding of m-CSFa reported the
presence of both monomeric and dimeric intermediates (Wilkins 1993). The
folding of m-CSFa involved a rapid formation ofa small amount of non-
native dimeric intermediates followed by a slow progression via both
monomeric and dimeric intermediates.After 45 min folding, three
intermediates were isolated and structurally characterized. Onemonomer122
contained two native disulfide bonds (Cys48-139 and Cys7-90), another
monomer contained three native disulfide bonds (Cys7-90, Cys48-139, and
Cys102-146), and a dimer had all native disulfide bonds except Cys102-146
and Cys'102-146.Itis unclear whether this dimer was the same one
referred to as the non-native dimeric intermediate detected in early folding.
However, it is evident that m-CSFa folded via multiple pathways. Several
similarities exist between the folding processes of m-CSFa and m-CSF13.
First, the folding of both proteins involve parallel pathways and supported
the folding funnel model.Second, disulfide shuffling occurred in both
folding processes and represented an important step in the conversion of
unfolded polypeptides to folded proteins.
Despite a few general similar folding characteristics between m-
CSFa and m-CSF13, there is evidence for significant differences in the
folding processes for the two proteins. The folding of m-CSFa was initiated
by diluting the denatured and reduced monomer 10-fold without the addition
of any chemical oxidant. The transition from monomer to fully folded dimer
was complete within 25 hr at room temperature.In contrast, the folding of
m-CSFI3 approached completionafter120 hrinthe presenceof
GSSG/GSH at room temperature. When glutathione was excluded from the
folding reaction, the rate of folding slowed significantly, requiring at least six
days of folding to approach completion.Clearly, the presence of four123
cysteine residues, Cys157, Cys159, Cys'157 and Cys'159, greatly
complicated the folding process in m-CS93, requiring much more time to
complete than for m-CSFa under similar conditions.
Disulfidebonds Cys157/159-Cys'157/159 were foundnot be
important for the biological activity or thermodynamic stability of rhm-CSFI3
(Zhang 2001).Consequently, the roles of Cys157/159-Cys'157/159 were
thought to involve the maintenance of some structural order in the C-
terminal regions of the protein.However, the present study showed that
Cys157/159 and Cys'157/159 formed early in folding, muchsooner than
Cys31-Cys'31. Because Cys157/159-Cys'157/159 were involved in the
initial dimerization, they must play an important role in subunit association.
Residues Cys157, Cys159, Cys'157 and Cys'159 were located in the C-
termini where little structural organization existed.It is possible that they
were more available for intermolecular interaction than Cys31 and Cys'31,
which could be made unavailable by the conformationalrestrictions
presented by nearby secondary structural units formed early in folding.124
4.5Material and methods
4.5.1Materials.
Reduced and oxidized glutathione were obtained from Sigma
Chemical Co..lodoacetamide was purchased from Fluka.Pre-packed
Sephadex G-25 PD10 columns were acquired from Pharmacia Biotech.
Pepsin was purchased from Pierce. All other reagents were of the highest
grade commercially available.
4.5.2 In vitro folding monitored by disulfide bond quenching.
Denaturation and disulfide bond reduction of the native rhm-CS93
was achieved by diluting the protein 10-fold into 50 mM Tris buffer (pH 8.5)
containing 9 M urea, 0.25 M DTT and 5 mM EDTA. The samplewas
incubated at room temperature for 3 hr.Utilizing a Hi Trap column, in vitro
folding was initiated by rapid buffer exchange of the denatured, reduced
protein solution into the folding buffer that contained 50 mM Tris (pH 8.5),
0.4 M urea, 5 mM GSH and 0.64 mM GSSG.The finalprotein125
concentration in the folding reaction was 0.3 mg/ml. At various times
ranging from 10 s to 7,200 min, the folding reaction was quenched by
adding 25 mM iodoacetamide to reaction aliquots.
Carboxyamidomethylated protein mixtures were analyzed using a LC-10AD
double-pump system coupled to a PE-Sciex API III+ mass spectrometer. A
capillary column packed with Vydac C4 TP214 material (5gm particle size,
300 A pore size, 5 gUmin flow rate) was used. The binary gradient elution
included 0.05% trifluroacetic acid (TFA) as solvent A and ACN containing
0.05% TFA as solvent B. The proteins were eluted using an 8-min gradient
from 10% to 90% B. MS spectra were analyzed by PE Sciex software
(Mac Spec and BioSpec).
4.5.3 Isolation of folding intermediates.
Denatured and disulfide bond reduced rhm-CSFI3 was preparedas
described above.After various folding times, the folding reactionwas
stopped by adding 25 mM iodoacetamidetothefoldingsolution.
Carboxyamidomethylation was performed at room temperature for 5 min.
The alkylated protein mixture (0.5 mg, 10 nmol)was analyzed by reversed
phase high performance liquid chromatography (RP-HPLC)on a Vydac C4126
TP214 column (300A, 5 gm, 4.6X250 mm, 1mUmin flow rate)
employing a binary linear gradient with 0.1% TFA as solvent A and
acetonitrile (ACN) containing 0.09% TFA as solvent B. The proteins were
eluted using a 60 min 44-54%B gradient.Protein fractions were collected
manually and dried in a Speed-Vac (Savant).
4.5.4 Identification of folding intermediates.
Fractions collected from freeze-drying were resuspended in 100 mM
phosphate buffer (pH 2.5). Each fraction was added to 8 M urea and 1 M
TCEP in order to remove the existing disulfide bonds.Denaturation and
disulfide bond reduction were allowed to proceed for 30 min atroom
temperature. Subsequently, the proteins were incubated with immobolized
pepsin (protein/enzyme=1:2) for 10 min at room temperature. The peptic
peptides were analyzed using a Waters HPLC equipped with twopumps
coupled to a Finnigan quadrupole ion-trap mass spectrometer. A capillary
column, packed with C18 Luna material (5 gm particle size, 300 Apore
size, 5 gUmin flow rate), was equilibrated in H2O containing 0.03% TFA
and eluted with a linear gradient of acetonitrile containing 0.03% TFA of127
10% to 60% over a 90 min period. The peptic peptides were identified
by CID- MS -MS.
4.5.5 In vitro oxidative folding monitored by H/D pulsed labeling.
Denaturation, disulfide bond reduction and oxidation of rhm-CS93
were performed as described above. At folding times ranging from 10 s to
7,200 min, aliquots were removed from the folding reaction and subjected
to a 10 s deuterium pulse by diluting the protein sample 10-fold into 50 mM
Tris buffer (pD 8.5). Deuterium pulsed labeling was quenched by reducing
the final pH to 2.5 and the temperature to 0°C. Samples were stored in
liquid N2 prior to mass spectrometric analysis. Unlabeled protein (0%
reference) was prepared by dissolvingnative rhm-CSFOin0.1 M
ammonium phosphate buffer (pH 2.5, 0°C, 1:1 D20/H20). The completely
deuterated protein (100% reference) was prepared by incubating rhm-CSF8
in 8 M urea-d4/D20 at 37°C for 6 hrs.128
4.5.6 Electrosprayionizationmass spectrometryofdeuterated
samples.
The samples from pulsed labeling experiments were thoroughly
desalted by washing with 0.03% TFA/H20 using a C4 Micro Trap (Michrom
BioResources, Inc) installed in the injector. Protein samples were analyzed
by LC-ESI-triple quadrupole MS (PE-Sciex API III+) using a custom-packed
C4 column (5 gm particle size, 300 A pore size, 20 gUmin flow rate) and a
binary gradient elution involving 0.03% TFA as solvent A and ACN
containing 0.03%TFA as solvent B. The protein was eluted using a 3 min
10-80% B gradient.The HPLC injector and column were submerged in
ice/water slurry, and the transfer syringe was pre-cooled on ice before use.
MS spectra were analyzed by BioSpec software.
4.5.7 Data analysis
Because the HPLC elution was performed with protiated solvents, a
small number of deuteriums at the amide positions are lost.Corrections
were made for this deuterium loss according to eq. 6 (Zhang & Smith,
1993):129
D = [(m-mo%)/(mi00% mo%)] x N Equation 6
where D is the number of deuteriums present in a particular peptide
segment or protein after incubation in deuterated solvent, and m, m0%, and
m100% represent the average molecular weight of a peptide or protein
obtained for non-deuterated, partially deuterated and completely deuterated
samples, respectively.N is the total number of exchangeable amide
hydrogens in the protein or the peptide of interest.
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5 Summary
Elucidation of the pathways of protein folding and unfolding has
remained one of the most difficult tasks in protein chemistry. For proteins
containing disulfide bonds, unfolding and folding can be followed by
reduction and oxidation of the native disulfide bonds. The breakage and
theformationofdisulfidebonds can be chemically trapped and
characterized. Therefore, the disulfide bond coupled folding and unfolding
pathways can be constructed based on the heterogeneity and structures of
the trapped intermediates. Unfolding of a protein containing disulfide bonds
can be achieved by reducing disulfide bonds in the absence of denaturant,
a method referred to as reductive unfolding. In oxidative folding, a disulfide
bond reduced protein is oxidized to recover its native disulfide bonds and
native conformation as well as biological activity.Under the same
conditions, reductive unfolding and oxidative folding exist in equilibrium,
which can be shifted by adjusting the experimental condition.
In rhm-CSFO, the assembly ofits monomeric subunits and its
maturation of the biological activity depend on the progressive formation of
the correct disulfide bonds during in vitro folding (Glocker, Arbogast et al.
1994). Clearly, the formation of native disulfide bonds is intimately linked to133
attaining the native three-dimensional structure. Knowledge about the
conversion from the reduced to the native rhm-CS93 can be obtained by
studying the intermediates isolated from the reductive unfolding pathway as
well as those from the oxidative folding pathway.The goal is to obtain
disulfide-bonded intermediates and determine their thermodynamic and
kinetic properties..Inthis project, intermediates from both reductive
unfolding and oxidative folding pathways of rhm-CS93 were isolated and
structurally characterized.
Reductive unfolding was initiated by incubating rhm-CS93 with a
reducing agentinthe absence of any chemicaldenaturant. One
intermediate was isolated and identified as CN157'159-modified rhm-CS93.
The removal of disulfide bonds Cys157/159-Cys'157/159 did not affect the
biological activity of the protein nor its stability.However, a comparison of
H/D exchange kinetics of rhm-CS93 and CN157'159- modified rhm-CS93
indicated that the C-terminal regions of the protein became more exposed
to solvent while structures in other regions of the protein remained the
same.These results suggested thatdisulfide bonds Cys157/159-
Cys'157/159 served to maintain some structural order in the C-termini.
To assess the roles of disulfide bonds Cys157/159-Cys'157/159 in
folding, D/H pulsed labeling was employed to monitor the foldingprocesses
ofureadenaturedrhm -CSFI3andCN1157159-modifiedrhm-CS93.134
Denaturation was performed in the absence of any reducing agent.
Therefore, the unfolded proteinsretained theintactnativedisulfide
structures: rhm-CSF8 maintained allnine native disulfide bonds and
CN1157'159-modified rhm-CS93 contained seven native disulfide bonds.
Deuterium exchange data indicated that both proteins attained secondary
structures within 7.5 ms and did not experience further structural change as
folding proceeded to 48 hr.These results suggested that the folding
kinetics of oxidized rhm-CSF8 were not affected by the absence of
Cys157/159-Cys'157/159.However, itis possible that the folding of the
denatured protein was affected but the effects were not readily detected by
D/H pulsed labeling.
Extensive effort was devoted to isolating other disulfide-bonded
intermediates in order to construct the unfolding pathways for rhm-CSFI3.
Various experimental parameters for the disulfide bond reduction were
carefully adjusted, including TCEP/SH stoichiometry, reaction times, and/or
reaction temperature (Appendix 2).However, these procedures did not
produce any homogeneous,partiallyreducedintermediates whose
structures and stabilities could be characterized.Consequently, the
reductive unfolding study was not fully successful in constructing the
unfolding pathways for rhm-CSF13.135
Oxidative folding of rhm-CSFp was investigated by monitoring
the structural changes that occurred as the denatured and reduced rhm-
cs93 folded into the native state with the aid of a chemical oxidant. rhm-
CSFp folding, monitored by disulfide bond quenching and H/D pulsed
labeling, was conducted under the same conditions, including the same
protein concentration, oxidant concentration, i.e. GSH/GSSG ratio, reaction
temperature, pH, and folding times.Therefore, these two experiments
provided results regarding the same intermediates in the folding pathways.
rhm -CSFJ3 folding was characterized by a heterogeneous mixture of
monomeric and dimeric intermediates, indicating that rhm -CSFf3 folded via
multiple pathways. The disulfide structures of seven intermediates were
identified. These data indicated that disulfide bond shuffling catalyzed by
GSH/GSSG represented an important isomerization process during folding.
A dimeric intermediate, D-SS8-cam2, represented a kinetic trap whose
conversion to the native protein was slow, perhaps because significant
structural rearrangement was necessary for D-SS8-cam2 to convert to the
native protein.H/D pulsed labeling data indicated that many intermediates
exhibited similar solvent accessibility making the structural characterization
of individual species impossible.
The roles of disulfide bonds Cys157/159-Cys'157/159 in folding must
be examined in the contexts of folding (from the protein containing intact136
disulfide bonds) and oxidative folding (from the denatured and disulfide
bond reduced protein).In the presence of seven native disulfide bonds,
rhm-CSFp folding proceeded very quickly and Cys157/159-Cys'157/159 did
not seem to play any important role.By contrast, when folded from the
reduced protein, folding required much more time to complete and
Cys157/159-Cys'157/159 facilitated the initial subunit association. Clearly,
Cys157/159-Cys'157/159 demonstrateddifferentactivitiesindifferent
folding systems. In the presence of the seven native disulfide bonds, non-
covalent forces were quickly restored and Cys157/159-Cys'157/159 only
assisted the local folding in the C-termini.In the absence of other native
disulfide bonds, Cys157/159 and Cys'157/159 served to link the subunits,
perhaps because they were located in less structurally confined regions and
therefore could easily form inter-subunit contacts.
Traditionally, protein folding was understood as a sequential process
involving obligatory intermediates. However, in the context of a "new view"
on protein folding, the concept of discrete folding pathways has been
superseded by three dimensional energy landscapes or folding funnels,
which depict the energetic search to the native state (Dill 1997). Sucha
view does not preclude the concept that folding might stilloccur via
preferred routes and defined intermediate states can still be envisioned
(Lazaridis 1997).Information taken from the oxidative folding studies137
indicated that the folding of rhm-CS93 was not a simple sequential
formation of native disulfide bonds. The time-dependent folding events
revealed that rhm-CSFI3 molecules passed through both monomeric and
dimeric intermediate states, suggesting that the denatured and disulfide
bond reduced rhm -CSFI3 folded via multiple pathways. These data clearly
depicted rhm-CS93 folding as a complex energy surface.
Inordertodescribetheenergylandscapeindetail,the
thermodynamic and kineticproperties of the intermediates must be
determined in addition to their structural characterization.In the present
study, the stability of CN157159-modified rhm-CS93 was obtained by
equilibrium unfolding experiments, which require large quantities of protein
material (mg).Becauseitisdifficult to prepare large quantities of
homogeneous material, the stabilities for the intermediates isolated in
oxidative folding were not determined.The relative stabilities of folding
intermediates can also be assessed by the computation approach. The
goal of a successful computational analysis is to carry out a well-defined
procedure that results in the ab initio folding of polypeptide and obtain the
free energies for various protein conformations. Energies calculated for the
folding intermediates can help assign their positions on the energy
landscape.138
A major challenge in studying rhm -CSFI3 folding results from the
difficulty of isolating intermediates. As indicated in the oxidative folding
study, many more disulfide-bonded intermediates were present in folding
(900,000,000 possible disulfide bonded isomers). However, onlya few were
structurally analyzed because other intermediates were transient and did
not accumulate in folding. To study the structural and energetic properties
of intermediates with other disulfide structures, rhm-CS93 folding should be
investigated with mutants in which some cysteine residues have been
substituted (Horovitz 1990; Roder 1997).In such studies, the effects of
replacing certain cysteine residues on therelativestabilitiesof the
intermediates can be assessed. Structural characterization of various rhm-
CS93 mutants should allow additional details of the conformation of the
intermediates to be inferred.Replacements at different cysteine sites
should yield distinct effects on both conformation and stability of the
intermediates at different stages in the folding pathways.Both genetic
(Zavodszky 2001) and chemical (Drakopoulou 1998; Pegoraro 1999)
methods can be utilized to prepare mutant proteins for structural studies.
However, the results from experiments on mutants must be carefully
interpreted because amino acid replacements may alter different properties
of the native, unfolded, and intermediate states of rhm-CS93.139
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Appendices153
A.1. The BioLogic QFM-400 instrument for quenched flow experiments.
Chemical quenched flow experiments involve fast mixing of two
reactants followed by quenching of the reaction with a chemical agent.
These experiments are facilitated by quenched flow instruments in which
drive motors are used to force the reactants into a mixer.The mixed
reactants pass into a reaction delay line where the reaction is allowed to
take place for a desired time period. The duration of the reaction is
determined by the volume of the reaction delay line and the flow rate of the
reaction mixture through the delay line.In practice, the reaction time can
be varied by changing the delay line and/or the flow rate through the delay
line.The reaction mixture then passes through another mixer where the
quench-solution is added to terminate the reaction. The reaction product is
collected by purging the contents through the exit purge port via a syringe.
The BioLogic QFM-400 instrument consists of four syringes (S1, S2,
S3 and S4) which are driven by four motors (Figure A.1).154
Collect
Mixer 2 Mixer 3
Mixer 1 n Delay line 1 Delay line 2
S1 S2 S3 S4
Waste
Figure A.1. The BioLogic 4-syringe mixer in the quenched flow mode.
Because the drive rates of the motors are independent of each other,
different mixing ratios can be obtained by selecting syringes of different
sizes. The BioLogic QFM-400 instrument contains three mixers and two
delay lines that allow maximally three reactions to take place, including a
final quenching reaction. At mixers 1 and 2, the reaction mixture is allowed
to proceed in delay linel and delay line 2. Volumes of the delay lines are
fixed by the delay line discs (17, 40, 90, 190 ul) which can be placed at
mixer 1 and 2 in any combination. However, the actual delay line volumes
include the volumes of the lines connecting the discs. Therefore, the actual
delay line volume for the 17 ul disc is 43 ul at mixer 1 and 53 ul at mixer 2.155
The actual delay line volume for each delay line disc at each mixer
position can be obtained from the MPS32 software set-up window or by
calculation as described in the manual. The reaction time at each mixer is
calculated by dividing the actual delay line volume at the mixer by the total
speed, which is the sum of the speeds of all preceding syringes. The flow
rate at each syringe can be adjusted individually from 0 mVs to 5 ml/s by
choosing the syringe of an appropriate size. The 20-m1 syringe allows a
syringe speed of 0-6 ml/sec (flow rates above 5 ml /sec require a preceding
ramping phase).
The BioLogic QFM-400 module is operated by the MPS32 software
program, which can perform automated movement of the syringes and
create a drive sequence. Writing a drive sequence is central to attaining
success with the BioLogic instrument. When creating a drive sequence, it
is important to realize that only a portion of the reaction mixture is collected
at the exit port.Therefore, the entire system must be cleaned prior to
initiating a reaction by washing with a buffer three times the volume of the
delay line volume at mixer 1. For a disc of 190 ul at mixer 1, approximately
600 ul of buffer is necessary to ensure that the reaction chamber is free of
contamination from the previous experiment. The MPS32 allows for up to
20 phases to be included in a drive sequence. The first phase in a drive
sequence often represents a washing phase. There are several important156
considerations for constructing a drive sequence. First, the total speed
through each mixer must be greater than 1 ml /sec and less than 12 ml /sec
and must remain the same from one phase to another.Second, the
reaction time must remain the same from one phase to another.To
construct a drive sequence that allows for a wide range of mixing times, the
easiest way is to write a sequence that allows the shortest reaction time in
the continuous mode and lengthen the reaction time by incorporating the
interrupt mode. To ensure that the drive sequence is correctly constructed,
the hydrolysis of DNAP can be used to verify proper mixing at each mixer in
the sequence as described in the manual.
A drive sequence for deuterium/hydrogen (D/H) exchange pulsed
labeling is provided as an example (Chapter IIIexperiments).In this
experiment, an unfolded, fully deuterated protein is refolded in a deuterated
buffer over variable time periods (11X dilution), then subjected to a 10 ms
labeling pulse with a protiated solvent (2X dilution), and finally quenched by
1 M HCI. In the QFM-400 instrument, S1 contains the deuterated, refolding
buffer, S2 contains the fully deuterated and unfolded protein solution, S3
contains the labeling buffer, and S4 contains 1 M HCI. The protein folding
reaction takes place at mixer 1; the D/H labeling reaction takes place at
mixer 2; and the quenching reaction occurs in the exit line.157
In order to achieve the 11X dilution at mixing stage 1, a 5 ml
syringe must be installed in S2 with syringes of 20 ml installed in S1, S3
and S4. Because the addition of an interrupt phase immediately after the
mixing phase can extend the reaction time at a mixer, a drive sequence is
written to achieve the smallest reaction time.In this case, the 17 ul disc is
used at delay line 1 and a 40 ul disc is used at delay line 2.Thus, the
actual reaction volumes at delay lines1and 2 are 43 ul and 60 ul,
respectively.The first phase is the wash phase, which requires 3X the
volume of delay line 1 (Table A.1)
Table A.1. A driving sequence for a deuterium pulsed labeling experiment.
Phase 1 2 3 4 5 6
Duration
(ms)
20 20 Variable
times
6 5 10
S1 (ul) 120 110 36 60
S2 (ul) 10
S3 (u1) 36 60
S4 (u1) 48
Valve wastewaste waste waste collect
Therefore, the volume in S1, containing the less precious between the
deuterated solvent in S1 and the deuterated protein in S2, is 120 ul and the158
duration is 20 ms providing a speed of 6 ml/s at mixer 1.In phase 2, S1
(110 ul) and S2 (10 ul) are mixed for a time period of 21 ms, which provides
a total speed of 6 mVs at mixer 1. Thus, the actual reaction time is 7.2 ms
(43u1/(6m1/s)).For reaction times longer than 7.2 ms, a third phase
extending the reaction time can be added. In phase 4, the refolded protein
mixture (product formed at mixer 1) is reacted with the labeling pulse in S3
in a 1/1 ratio.Delay line 2 has an actual volume of 60 ul. As a result of
diffusion, 1/3 of the solution at the front-end experiences improper mixing
and must be removed. Consequently, the duration time is 6 ms, S1 pushes
36 ul yielding 6 ml/s at mixer 1, S3 pushes 36 ul yielding 6 mVs at mixer 2.
The actual delay line volume is 60 ul yielding an actual reaction time of 5
ms (60u1/(12mVs)).The designated reaction time is 10 s, therefore a
duration of 5 ms can be added in phase 5. The pulsed labeling reaction of
the refolded protein is quenched in phase 6 by adding 1 M HCI in phase 6.
The duration time is 10 ms, S1 pushes 60 ul to maintain 6 ml/s at mixer 1,
S3 pushes 60 ul to maintain 6 mVs at mixer 2, and S4 pushes 48 ul to
achieve a desirable final pH of 2.5.159
A.2.Sequential disulfide bond removal
The sequential disulfide bond removal approach makes use of the
partial reduction of a protein under controlled conditions and produces a
protein in which reduction has opened some, but not all disulfide bridges.
Every disulfide bond has the same redox potential and should be reduced
to a similar extent based on thermodynamic considerations.However, in
the solution of a native protein the reduction kinetics of various disulfide
bonds are quite different depending on their accessibility to the reducing
agents and on the conformationalstabilityof thedisulfidebonds.
Theoretically,itis possible to achieve sequential reduction of disulfide
bonds by controlling the reduction conditions.
Dimeric rhm-CSFI3 is linked by two four-helix bundles, forming an
extremely flat, elongated structure (Figure 4). There are three intra-subunit
disulfide bonds in each monomer including: Cys7-Cys90, Cys48-Cys139,
Cys102-Cys146.All intra-subunit disulfide bonds are at the end distal to
the dimer interface.One inter-subunit disulfide bond, Cys31-Cys'31, is
located at the dimer interface. The total surface buried by dimerization is
-850A2 from each monomer which constitutes about 9% of the total
exposed area of a monomer. Two inter-subunit disulfide bonds linking
Cys157/159 and Cys'157/159 are located in the C-terminal regions.It is160
unclear whether Cys157 forms a disulfide bond with Cys'157 or
Cys'159.Nonetheless,itis evident that these cysteine residues form
symmetrical disulfide bonds that are in close proximity in the three-
dimensional space.
The sequential disulfide removal strategy has been applied to study
the reductive unfolding of rhm-CS93. The objective was to remove disulfide
bonds pair by pair in order to isolate various homogeneous, partially
reducedintermediateswhosestructuresandstabilitycouldbe
characterized.The partialreduction conditiondidnot include any
denaturant. Reduction was carried out with TCEP at pH 3.5 where disulfide
bond scrambling was minimal. The reduced cysteine residues were
irreversibly alkylated by CDAP at pH 3.5. The mixture contained residual
intact protein and partially reduced, cyanylated isomers that were separated
by reversed phase HPLC.The purity of the isolated fraction was
determined by ESI-MS.
Themixtureofpartiallyreducedrhm-CSFI3 oftencontained
intermediates with different reduction states.Therefore, experimental
parameters were varied to (1) increase the yield of the predominant product
in a given mixture (2) and to produce different reduction products (Figure
A.2).161
MCSF in citrate buffer pH 3.5 TCEP at various conc.
12.5 ul X 8ug/u1 (2 nmol) in citrate buffer pH 3.5
50u1
citrate buffer pH 3.5
37.5 ul varied temp
varied time
protein mixture
remove TCEP
by buffer exchange
CDAP in citrate buffer pH 3.5
20 X 18 X 2 nmol
(20 molar excess of total SH)
110 min
room temp
RP-HPLC fractionation
Figure A.2. Scheme for partial reduction of rhm-CSFI3.
The results obtained from these experiments are summarized in Table A.2.
Under strong reducing conditions, i.e. under high TCEP/SH stoichiometry,
extended reaction times, and/or high reaction temperature, more disulfide
bonds were reduced and more cysteine residues alkylated.Monomeric
proteins were produced in some cases.Most protein species were not
homogeneous and contained various disulfide bridges.162
Table A.2. Individual parameters adjusted in the partial reduction of
disulfide bonds in rhm-CS93. Bolded molecular weights represent the
predominant species in the HPLC fractionations.
TCEP/SH
(moVmol)
Rxn time Temp (°C)
(hr)
MW (Da) #CN
50X18 / 1 2 28 24,628, 49,030, 49,1684.2, 0, 5.52
50X18 / 1 3 28 24,627, 49,030, 49,2174.2, 0, 7.48
50X18 / 1 4 28 24,629, 49,030 4.2, 0
50X18 / 1 5 28 24,627, 49,030 4.2, 0
50X18 / 1 6 28 24,734, 49,030 8.5
5X18 / 1 1 28 49,030, 49,107 0, 3.08
5X18 / 1 3 28 49,030, 49,145 0, 4.6
5X18 / 1 5 28 49,030, 49,136 0, 4.24
5X18 / 1 7 28 49,030, 49,148 0, 4.72
5X18 / 1 10 28 24,695 6.84
1X18 / 1 1 28 49,030, 49,146 0, 4.64
1X18 / 1 3 28 49,030, 49,146 0, 4.64
1X18 / 1 5 28 49,030, 49,148, 49,1680, 4.65, 5.52
1X18 / 1 7 28 49,030, 49,156, 49,2350, 5.04, 8.2
1X18 / 1 10 28 24,695, 24,730, 49,0306.84, 8.24, 0
0.5X18 / 1 1 28 49,030, 49,150 0, 4.8
0.5X18 / 1 2 28 49,030, 49,146, 49,1560, 4.64, 5.04
0.5X18 / 1 3 28 49,030, 49,146, 49,1510, 4.64, 4.84
0.5X18 / 1 4 28 49,030, 49,152 0, 4.88
0.5X18 / 1 5 28 49,030, 49,136, 49,1400, 4.24, 4.4
0.5X18 / 1 7 28 49,030, 49,170 0, 5.6
0.5X18 / 1 9 28 24,696, 49,030 6.88, 0
0.05X18 / 1 1 28 49,030, 49,070 0, 1.6
0.05X18 / 1 3 28 49,030, 49,089, 49,1310, 2.36, 4.04
0.05X18 / 1 5 28 49,030, 49,131 0, 4.04
0.05X18 / 1 7 28 49,030, 49,130, 49,1560, 4, 5.04
0.05X18 / 1 10 28 24,695, 49,030, 49,2416.84, 0, 8.44
0.05X18 / 1 5 35 49,030, 49,131 0, 4.04
0.05X18 / 1 5 45 49,030, 49,130, 49,1560, 4, 5.04
0.05X18 / 1 5 55 49,030, 49,130, 49,1560, 4, 5.04
0.05X18 / 1 5 65 24,695, 49,030, 49,1566.84, 0, 5.04
0.05X18 / 1 5 72 24,695, 49,030 6.84, 0